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Ie Introduction 
The skin test is a widely employed method for the demon-
stration of past or present infection with respiratory or 
systemic mycotic invaders. The terms histoplasmin and blasto-
mycin are currently used to indicate the filtrate derived from 
the prolonged growth of the mycelial phase of Histoplasma 
capsulatum and Blastomyces dermatitidis respectively in liquid 
media. Unfortunately, it is not clear from reports of many 
investigations on histoplasmin and blastomycin skin tests, 
whether the product and the given dilutions are comparable to 
any other histoplasmin or blastomycin preparations. The 
National Institutes of Health have partially resolved this 
problem by preparing standard histoplasmin for comparative 
studies and by publishing regulations that must be satisfied 
before a histoplasmin product may be marketed. However, similar 
standardization of blastomycin and coccidioidin has not been 
achieved& The working hypothesis was proposed, that if a known 
weight of a mycotic skin test antigen could be employed diag-
nostically, this substance would have the same advantages that 
P.P.D. has in tuberculosis. 
In the following literature review, investigations are 
considered which were designed to isolate and study serological, 
skin test and/or chemical properties of polysaccharides derived 
from H. capsulatum and B. dermatitidis. 
II. Histoplasmosis 
A. Introduction. Histoplasmosis is a fungus infection 
caused by Histoplasma capsulatum. Manifestations of this 
disease range from minute localized lesions to chronic or acute 
generalized systemic disease. Since the organisms, once phago-
cytized, persist in the phagocytic cells of the systemically 
infected individual, the infection is said to have a predilection 
for the cells of the reticulo-endothelial system. Asymptomatic 
pulmonary involvement is not unusual. The disseminated disease 
yields a mortality rate of 50 to 98 percento The fungus is widely 
distributed and histoplasmosis is particularly prevalent in the 
central part of the United States. 
Bo History. Darling (1) described the first case of histo-
plasmosis in 1906. At the time of this discovery, Darling was 
searching for leishmaniasis in Panama. He observed, in necropsy 
specimens from a Martinique negro, small, round, capsulated 
organisms & Darling recognized that these organisms were not 
Leishman-Donovan bodies. He concluded, from his morphological 
study, that these organisms were protozoa and proposed the name 
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Histoplasma capsulatume In 1908, and again in 1909, Darling 
reported (2) similar organisms which he observed in tissues 
from another negro and a Chinese shopkeeper • 
. ' The mycotic, rather than the protozoan, nature of this 
organism was reported by DeMonbreun (3), in 1934. He was able 
to culture the organisms from a human infection, and also from 
an infected doge 
C. Epidemiologye For a long period after the recognition 
of the disease by Darling, histoplasmosis was believed to be 
a rare tropical diseaseo Following Darling's investigation, 
further cases were not reported until 1926. 
The studies of C. E. Smith, ~ alo, on coccidioidomycosis 
and particularly on the use of coccidioidin (4) for epidemio-
logic surveys, aroused the interest of investigators in other 
parts of the United States. Christie and Peterson (5), in 1945, 
were conducting tuberculosis surveys among children in Tennessee. 
During-the course of the survey, they found 181 children with 
negative tuberculin skin tests, but radiologic evidence of lung 
lesions. These investigators tested the leI children with coc-
cidioidin and found no markedly positive reactions. The same 
children were also skin tested with a broth filtrate from the 
growth of He capsulatum, and a high percentage of reactors were 
noted. Christie and Peterson concluded from this study that 
there was an immunogenic relationship between the observed pul-
monary calcifications and histoplasmosis. During this same year, 
Palmer (6) reported a study of tuberculin and histoplasmin skin 
tests on 3,000 nurses in Detroit, Kansas City, Minneapolis, and 
Philadelphia. He concluded from these studies that: (1) histo-
plasmosis was a widespread subclinical infection, (2) persons 
from some states had a higher rate of infection than persons in 
other states, (3) that many of the lung calcifications were due 
to H. capsulatum and not Mycobacterium tuberculosis. Many 
other investigators (7-17) have extended the knowledge of the 
epidemiology of human histoplasmosis. This infection has been 
reported from many parts of the world (18-21), but an endemic 
focus of histoplasmosis was found in midland United States, 
extending the length of the Mississippi River Valley. 
Investigations of local outbreaks of histoplasmosis, in-
volving family size units, or small groups of persons, have been 
reported (22-23). The isolation of Ho capsulatum from these 
families and the indirect incrimination of dust as the source of 
the infection added to the possibility that soil might harbor 
H. capsulatum. The missing link in the life cycle of H. capsul-
~, the isolation of the mycelial spores from soil, was 
reported by Emmons (24), in 1949. Others (25-32) have confirmed 
and extended these resultso These investigators have been most 
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successful in isolating lie capsulatum spores from soil samples 
in or near chicken coops. Chickens, however, are not the 
reservoir of H. capsulatum. Many hypotheses have been suggested 
to explain histoplasmin sensitivity. Recently, Zeidberg- (33) 
reported a correlation between a world occurrence of red-yellow 
podzolic soils and histoplasmin sensitivity. The ability of 
the red-yellow podzolic soil to support the growth of H. capsul-
~ has not been reported. 
Evidence of a natural animal reservoir has never been 
clearly shown, although H. capsulatum has been isolated from 
dogs, cats, skunks~ cattle, rats, mice, horses, foxes, and 
woodchucks (34-40). The dog, and possibly the cat, have been 
examined in sufficient numbers to indicate that they might act 
as a reservoir for the infection. Since these animals live in 
close association with man, it is conceivable that dogs and 
cats may be infected from humans. It is also possible that 
man and his domestic animals are infected from a common source, 
such as soil. The association of H. capsulatum with soil in 
and around chicken coops, even though chickens cannot be shown 
to act as carriers of the disease, suggests rats or mice as a 
possible animal reservoir. Apparently, however, less than one 
percent of mice and rats have been found infected. A study of 
rodents indigenous to chicken coops might be of value. Until 
further studies on the animal or insect reservoir and growth 
factors within the chicken manure ~re made, histoplasmosis must 
be assumed to be contracted from the inhalation of spores of 
H. capsulatum that are present' in dust from chicken coops. How 
these spores get into the soil, and the length of time these 
spores remain viable in these soils is not yet known. 
There is no significant evidence to suggest that pulmon-
ary histoplasmosis is transmissable between humans. 
De Experimental Histoplasmosis. Investigations in the 
field of experimentally induced H. capsulatum infections have 
revolved around the following three basic problems: 
(1) Search for susceptible laboratory animals; 
(2) Methods for quantitating the number of organisms 
injected into these animals; 
(3) Search for a route of inoculation that would yield 
reproducible morbidity and mortality. 
Obviously, these problems are interrelated. 
Dogs, rats, hamsters, guinea pigs, monkeys, and mice have 
been used as experimental animals (41-44). White mice appear 
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to be the most useful experimental animal. Variations in 
the susceptibility of different mouse strains have been 
reported (45), thus the choice of strains or species of mice 
is important in experimental work. 
Usually, the dose of organisms injected is reported as 
a dilution of the original suspension. The assumption made 
is that one dilution of 1-100 equals any other dilution of 
1-100, with respect to the number of viable organisms. 
Howell, ~ al., (46) have published a method in which viable 
plate counts are made from an aliquot sample of the inject-
ing suspension. A more direct method for standardization of 
H. capsulatum suspensions has been most recently described 
by Marcus and Rambo (47) and Rowley and Huber (48). As is 
usual by the method employed, counts are made of the numbers 
of cells in a hemocytometer. The total number of H. capsul-
atum per ml is then calculated. 
Massive numbers of H. capsulatum are necessary to kill 
mice when they are injected intraperitoneally. Gastric mucin 
has been employed as an adjuvant for inducing reproducible 
infection via the intraperitoneal route in mice (49). The 
intracerebral route of challenge has been reported as a useful 
method of inoculating mice (50). The small volume of inoculum 
(.02 ml) limits the number of organisms that may be injected 
intracerebrally, but these induce chronic histoplasmosis in 
the brain tissues, without further extension of the disease. 
Only occasionally do experimentally infected animals show 
macroscopic lesions of histoplasmosis at autopsy, but micro-
scopic and cultural examination of liver, spleen, and other 
tissues of these animals, usually reveal the yeast phase 
organisms of H. capsulatumo The intravenous route of injec-
tion of white mice with known numbers of H. capsulatum is the 
most dependable and reproducible method for the study of 
experimental histoplasmosiso 
Ee Laboratory Confirmation of Histoplasmosis. 
Histoplasma capsulatum belongs to the Moniliacae of the Fungi 
Imperfecti. This fungus is a diphasic organism that grows 
in the yeast phase in the mammalian host, or on complex 
organic media at 37oC. It grows in the mycelial phase at 250 C. 
On Sabouraud's dextrose agar at 250 C the colony is at first 
small and cottony in appearance, but rapidly enlarges in size. 
As it enlarges, the colony slowly becomes tan to dark brown 
in color. Slide mounts (Henrici preparations) after two to 
three weeks, when viewed microscopically, show the following 
characteristics: 
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(1) Small undifferentiated spores; 
(2) Larger, round or ovoid, smooth spores, often on 
short stalkSj 
(3) Tuberculate, spherical to pear shaped chlamydospores 
which measure 10 to 25 microns in diameter. These 
spores constitute a major diagnostic characteristic 
of H. capsulatYm; 
H. capsulatum grows in the yeast phase on 10 percent 
blood agar at 37oC. The colonies appear grey in 
color, small, firm and vary in texture from a creamy 
consistency to a leathery type of colony, at first 
resembling colonies of staphylococci. 
The mycelial phase of He capsulatum is the infective 
stage. The usual portal of entry is probably the respiratory 
or the gastrointestinal tract. The lymphadenopathy frequently 
seen in histoplasmosis must be differentiated from that seen 
in the malignant lymphomas (51), tuberculosis and other fungus 
infections. Splenomegaly, hepatomegaly, and ulcerative enter-
itis also occure Widespread disease due to hematogenous dis-
semination is usually rapidly fatal. Mild cases may be 
asymptomatic. A benign primary infection caused by H. capsulatum 
may result in calcifications and roentgenographic findings 
which are indistinguishable from primary tuberculosis (52). 
Anergy can often be demonstrated in the moribund patient. The 
histologic lesions produced. as a result of fungus infections, 
are typically granulomatous, and may be mistaken for those of 
tuberculosis (53-55) unless the invading organisms are iden-
tified. Since fungi produce subacute or chronic infections 
which mimic tuberculosis, an accurate diagnosis of such disease 
must depend on careful laboratory studies of specimens obtained 
from infected patients. Such laboratory studies should include 
direct microscopic examination of sputum, cultures of sputum 
or biopsy material, tests of pathogenicity of organisms iso-
lated, skin and serologic tests. Culture of blood and bone 
marrow specimens (56) are sometimes helpful in confirmation of 
a diagnosis of histoplasmosis. 
Sabouraud's agar has for many years been used as the 
medium of choice for the isolation of fungi. Recently, the 
use of media containing blood and antibiotics have been 
reported (57,58) as most efficacious for the isolation of 
pathogenic fungi. Bacterial and saprophytic fungus inhibit-
ing agents, such as cycloheximide (acti-dione) have also been 
utilized for isolating pathogenic fungi (59). Chemically de-




The acquired immunity in histoplasmosis is not clearly 
definedo Much of the evidence available suggests that this 
disease occ'urs in primary infection and reinfection types, 
similar to those observed in tuberculosis. The hypersensitive 
state in histoplasmosis is associated with some degree of 
acquired immunity. The lesions in the hypersensitive patient 
are usually not as numerous or widely distributed, but a more 
violent inflammatory reaction is noted when the fungus mana-
ges to establish itself (63)0 
The previously mentioned parallelisms between tuber-
culosis and histoplasmosis extend to skin testing and sero-. 
logic diagnostic aids. As in tuberculosis, skin tests for 
histoplasmosis have been the most widely accepted method for 
demonstrating past or present He capsulatum infections. 
Histoplasmin was originally defined by Zarafonetis and 
Lindberg (64), as the antigenic substance or substances of 
H. capsulatum. The term histoplasmin is now used to indicate 
the filtrate derived from the growth of the mycelial phase 
of lio capsulatum in a liquid medium. Histoplasmin must be 
capable of producing a positive skin reaction in sensitized 
animals and man. Since 1945, an ever-widening interest in 
the use of histoplasmin has resulted in the publication of 
many reports on its epidemiologic, laboratory and clinical 
applications. Histoplasmin has been produced by the following: 
(1) Emmons and also Howell, at the National Institutes of 
Health; (2~ Christie and Peterson( at Vanderbilt University; (3) Eli Lilly' and Company, and (4) the Parke Davis Company. 
Unfortunately, it is not clear, in many investigations dealing 
with histoplasmin sensitivity studies, whether the product and 
the given dilution are comparable to any other histoplasmin. 
The National Institutes of Health have recently prepared 
standard histoplasmin for comparative studies, and published 
biologic regulations that must be satisfied before a histo-
plasmin product can be soldo 
An ideal antigen for skin testing, at a critical 
dilution, would give a minimum number of heterologous skin 
reactions, and a maximal number of homologous responses. 
The question of the specificity of fungus skin test antigens 
is of prime importance, because it has been shown that cross 
reactions occur among histoplasmin, blastomycin, and to a 
lesser degree with coccidioidin and haplosporangin. 
Complement fixation, precipitin, collodion particle 
agglutination, and hemagglutination tests have been used for 
the detection of humoral antibodies in mammals infected with 
Ho capsulatum. Histoplasmin has been employed as the antigen 
in lio capsulatum complement fixation tests. ijowever, the 
antigenic variability of different lots of histoplasmin (65) 
has made this antigen unsuitable for complement fixation 
studies. The most widely accepted complement fixing antigen 
is the cell free extract from yeast phase Ho capsulatum. 
Several methods for preparing this antigen have been reported 
(66-68)0 Histoplasmin adsorbed on collodion particles agglu-
tinates in the presence of antibody from rabbits and humans. 
Sheep erythrocytes, sensitized with histoplasmin, agglutinate 
when mixed with homologous antiserum from immunized rabbits 
(69)0 The use of the precipitin test, as an aid in'the 
diagnosis of human histoplasmosis, was investigated, after 
Co Eo Smith reported the value of the precipitin test in the 
early detection of antibodies in coccidioidomycosis. Salvin 
and Furcolow (70) reported the precipitin test to be of value 
in demonstrating li. capsulatum humoral antibodies that were 
not detected by concomitant complement fixation tests. The 
complement fixation test appears to be the most useful single 
serologic test presently available for the detection of humoral 
antibodies in histoplasmosis. 
The current interest in antigen-antibody reactions in 
gels is largely due to the work of Oudin (71), and Ouchterlony (72). The principle of these tests is the formation of a . 
visible precipitate of antigen and antibody ina solid medium, 
usually agaro Oudin has described a simple precipitin tube 
diffusion technic in which the antibody is mixed with agar. 
The antigen diffuses through the agar producing visible products 
of the antigen-antibody reaction. If the antigen contains more 
than one component, these components migrate through the agar 
at different rates. Each component reacts with the antibody 
forming zones of precipitate. 
Ouchterlony (72) used the same methods, except that he 
performed the test in petri dishes instead of precipitin tubes. 
Ouchterlony also devised a double diffusion reaction, by plac-
ing the antigen and antibody a few cm apart in wells in the 
agaro The reactants diffused through the agar, and when 
optimal proportions of antigen and antibody were achieved a 
line of precipitate formedo If there were more than one react-
ing component in the antigen, multiple lines of precipitate 
formed 0 He further found that he could place a number of 
antigens around the periphery of the agar plate, with the anti-
body in central wello If the antigens contained dissimilar 
reacting components, the lines of precipitation would 'cross 
over each other, while similar components formed continuous 
lines around the antibody well. 
Diphtheria toxin, pure by all physical and chemical 
methods, produces three lines of precipitate when reacted with 
antidiphtheria toxino The implication was that this method of 
reaction in agar was more sensitive than the most elaborate 
physical and chemical tests. 
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Fe Treatment. The antibiotics cyclohexamide (Acti-
dione), Ascosin, Amphotericin B and the chemical agents; 
ethyl vanillate, atabrine, methyl testosterone, sulfonamides 
and stilbamidines have been reported as useful in experi-
mental or human histoplasmosis (73-80)0 The results, however, 
are not conclusiveo At the present time, histoplasmosis must 
be considered resistant to treatment with available chemo-
therapeutic agentso 
III. North American Blastomycosis 
A. Introductiono North American blastomycosis is a 
specific infection caused by Blastomyces dermatitidis, a 
diphasic fungus that exists in tissue as a budding yeast, 
but which produces hyphae with conidia when grown at 250 C to 
300 e on most laboratory mediao 
Bo History. Gilchrist (81) first described the cutan-
eous lesions of this disease in 1894. A few months later, 
Busse, in Germany, described a similar organism. Busse coined 
the name Saccharomycosis hommis o Previously, the name blasto-
myces had been used to identify a species of fungus isolated 
from dung (82), but Gilchrist used the name Blastomyces derma-
titidis to indicate a fungus similar to a yeast found in skin 
lesions. Actually, the organism described by Busse, and many 
other European investigators,'was Cryptococcus neoformans. 
Gilchrist and Stokes, in 1896, (83) reported the successful 
cultivation of Bo dermatitidis on blood serum, glycerin agar, 
and potatoes. They found this organism fermented grape sugar 
to produce alcohol and carbonic acid. It is interesting that 
Flexner conducted the first successful animal infection by 
the intra-arterial injection of a Bo dermatitidis culture into 
a dog. White mice were also successfully infected, but much 
difficulty was experienced in the experimental infection of 
guinea pigs. The report of Gilchrist and Stokes was followed 
by an era of much confusiono For example: Gilchrist cited a 
number of papers in which uoidium fungi" were reported to 
cause a number of diseases such as sarcoma (84), adenocarcinoma (85), and myxomatous tumors of man (86). The European authors, 
during this time, were adding to the confusion by reporting' 
many cases of European "blastomycosis" or Cryptococcus ~ 
formans infections. 
The following excerpt from Gilchrist's paper in 1896 (83) clearly shows that he had cultured Be dermatitidis. 
"Young cultures consist of large refractive oval or round 
bodies showing a double contoured membrane, suggesting an 
episporium and endosporium and containing numerous refractive 
granules resembling fat dropso These bodies often showed 
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increase by budding and in time form short hyphae, numerous 
small knob-like projections of the limiting membrane which 
gradually enlarge and at last form large, round cells or 
conidia." 
Many names were proposed for the cutaneous and/or 
systemic form of this disease, however, Martin and Smith (87), 
in 1939, finally showed that North American blastomycosis was 
different from the European disease, and that Blastomyces 
dermatitidis had priority as a suitable name for the disease 
occurring in North Americao 
c. Epidemiology. Martin and Smith, in 1939, (87) found 
98 percent of 340 proved cases of blastomycosis had their 
origin within the United States. Two cases presumably origin-
ated outside this country, one in Canada (g8) and the other 
in England (R9). Presumptive cases have been reported from 
many other countries. 
The majority of the patients who developed blastomycosis 
in the United States came from the southeastern and midwestern 
states. Schwarz and Goldman (90) sent a questionnaire to 
1,569 dermatologists and 405 thoracic surgeons throughout the 
United States. This survey reported 101 cases of North Ameri-
can blastomycosis diagnosed, and/or treated during the first 
6 months of 1953. These authors considered the disease common 
throughout the United States. 
The precise mode of infection is not yet understood. 
It is generally presumed to be exogenous with the infective 
saprophytic form of the organism existing in the nature. How-
ever, Blastomyces dermatitidis, unlike Coccidioides immitis, 
Histoplasma capsula tum, Cryptococcus neoformans and Sporo-
trichium schenkii has not been isolated from any sources in 
nature. 
In a series of 16 canine cases collected from the litera-
ture by Ramsey and Carter (91), the disease was studied at 
necropsy in 13 of the dogs, and in all 13 there was extensive 
involvement of the lungso Four of the animals also had cutane-
ous lesions. The massive nature of the pulmonary disease, with 
few and in some cases no other lesions, suggested the possi-
bility of aerial transmission. In their study of canine histo-
plasmosis and blastomycosis, Menge, ~ alo (92), showed a ' 
striking similarity in the epidemiology of the two diseases, 
and the evidence points quite uniformly to the lungs as the 
primary site of infection. Of the 7 dogs studied by Menges, 
4 were examined histologically and 1 of the 4 was believed to 
have both histoplasmosis and blastomycosis. 
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Schwarz and Baum (93, 94) have expressed the op1n10n 
that blastomycosis occurs primarily as an infection of the 
lungs, which later disseminates, giving rise to lesions in' 
the skin, mucous membranes, bones, prostate gland, kidneys, 
and other tissuesc This would make the disease similar to 
histoplasmosis and coccidioidomycosis, with regard to mode 
of infection. Such characteristics also serve to distinguish 
the disease from sporotrichosiso In the latter disease, it 
is well known that the organisms are present in the soil and 
on certain plants, and that the infection is the result of 
traumatic injury which gives rise to cutaneous lesions, 
usually without pulmonary involvement~ The frequency of pul-
monary lesions, when no special attempt was made to demonstrate 
them, speaks strongly in favor of aerial transmission for the 
initial infection. It is assumed, as a working hypothesis, 
that the organisms growing in soil are in a filamentous form 
with the production of conidia which are disseminated in the 
air. If the evolution of the epidemiologic knowledge of 
North American Qlastomycosis is to follow that of coccidio-
idomycosis and histoplasmosis, this disease is essentially 
at the stage where only the rare, fatal disseminated disease 
is readily recognizedo In an attempt to demonstrate the 
existence of a prevalent benign North American blastomycosis, 
Furcolow and associates (17) conducted a skin test survey 
with tuberculin, histoplasmin, and blastomycin among 7,194 
school children in Hamilton County, Ohioo No supporting evi-
dence was obtainedo The 12per'cent positive reactions to 
blastomycin were regarded as cross reactions in persons show-
ing a positive histoplasmin skin test. One child was a 
blastomycin reactor, with a negative histoplasmin reaction. 
The possibility of the occurrence of mild infections can not 
be dismissed on the strength of negative skin test surveys. 
A verified epidemic of blastomycosis was observed by 
Harris and his coworkers (95) in Grifton, Pitt County, North 
Carolina. The sudden appearance of 10 pulmonary cases in the 
locality provided an excellent opportunity for epidemiologic 
investigations. A survey of the population of the town re-
vealed a number of individuals with positive blastomycin and 
negative histoplasmin skin tests. The source of the infection 
was not traced. 
Do Some Clinical Features. The clinical manifestations 
obviously-are determined by the extent of the disease and 
organs involved. While the idea of primary pulmonary infection 
has much evidence to support it, there probably are'sporadic 
cases without recogni;able lesions in the lungs (96,97). This 
is to be expect~d, since most of the fungi are opportunists 
and are not as a rule highly virulent agents dependent on a 
particular route or mode of spread. 
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In the skin, the lesions are heaped up, nodular, firm, 
worty, and likely to have small abscesses at the periphery 
(98}o As the lesions spread peripherally, a firm fibrotic 
plaque may be left in the center, but many times there is no 
central healing and the lesions take on the g~pss appearance 
of a large fungating mass (99,100)0 The lesions may be soli-
tary and persist for years with gradual extension, or they may 
be dissiminated with many nodules appearing on various parts 
of the body (101)0 At times, the skin manifestation is a form 
of subcutaneous abscess that erodes through the surface (102). 
The systemic form of the disease can involve any organ' 
of the body, but probably begins most frequently in the pul-
monary tract (103-105)0 The presenting signs and symptoms 
depend upon the organ or organs affected and the extent of the 
involvement (106-108)0 
Eo Laboratory Confirmatione Clinical diagnosis of blasto-
mycosis can only be presumptiveo The diagnosis is established 
by microscopic demonstration and cultural identification of the 
causative organismso The following examinations should be at-
tempted for the bacteriologic demonstration of the Bo dermatitidis 
(109-113): -
(1) Direct microscopic examination; wet mounts of all 
specimens submitted for fungal examination should 
be prepared by immersing a small portion of the 
specimen in 10% potassium hydroxide, in order to 
clear the specimen for microscopic examination 0 
These organisms appear as yeasts with double con-
toured walls and some cells show budding daughter 
cellso It is of diagnostic significance that the 
point of attachment between the mother and daughter 
cell is very wide, while other yeast, such as Candida, 
have a very narrow area of attachment between the two 
cel1so Air bubbles, oil droplets, and other cellular 
elements may be confused with yeast phase cells of 
fungio Yeast phase cells showing multipl~ budding 
rather than the single daughter cell are stlggestive 
of Blastomyces brasiliensise The failure to demon-
strate organisms in the wet mount does not rule out 
mycotic infectionse 
(2) Cultural procedures; regardless of the results of 
the wet m04nt microscopic examination, the clinical 
specimens should be culturede The growth and identi-
fication of lh. dermatitiEll.s on laboratory media con-
stitutes indisputable evidence of the infectiono 
Clinical specimens may be cultured on Sabouraud's 
dextrose agar at 370 C and r09m temperatureo Blood 
agar containing penicillin and streptomycin has been 
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used with ~uch success (58). The inclusion of 
antibiotics in ~his medium prevents bacterial 
contamination, but allows the fungi to grow unin-
hibited. Fungal colonies may appear as early as 
the third day after inoculation or at any time 
thereafter up to about 1 month. 
The diaphasic fungi (B. dermatitidis, H. Sapsulatum, 
and .§.. sopenkii) grow in th,e yeast phase at 370 0 
and in the mycelial ph~se at room temperature. 
c. immitis, although d1phasic, grows in the mycelial 
state at 370 C, but appears in the yeast phase in 
the infected animal. Typical oval or pyriform 
conidia of B. d2rmatitidis can best be demonstrated 
by the use of Henric i preparations. This method is' 
the most useful mycological procedure for the posi-
tive identification of ~. dermatitidis. Pathology 
laboratory reports on biopsy specimens, taken in 
conjunction with the cultural results, frequently 
establish a diagnosis with more assurance than can 
either procedure alone. 
(3) Animal inoculation; fulfillment of Koch's postulates 
by the inoculation of experimental animals such as 
guinea pigs and/or mice (114,115) is an often employed 
procedure. The intravenous or intraperitoneal inoc-
ulation is followed by the appearance of suppurative 
nodular lesions in the liver, spleen, lungs, and 
lymph nodes. Material from these leSions, as well as 
peritoneal washings, reveal typical yeast like 
tissue forms of B. dermatitidis. 
-
(4) Skin tests; cutaneous hypersensitivity in a patient 
with North American blastomycosis may be demonstrated 
by a skin test using a vacoine of the killed yeast 
phase organism or a culture filtrate called blasto-
mycin (116-118)0 The blastomycin skin test is akin 
to the tuberculin test involving similar technique of 
performance, reading and significance. The intra-
dermal injection of 0.1 ml of a standardized antigen 
in dilution of 1:10 to 1:100,000 depending upon the 
degree of sensitivity, results in the appearance of 
maximal induration and erythema in 24 to 48 hourso 
A positive blastomycin skin test generally indicates 
a past or present infection. Although this test is 
only presumptive diagnostic evidence, the test is 
particularly helpful in mild, obscure cases, or in 
cases where material for biopsy or culture can not 
be obtainede The full significance of the blastomycin 
skin test has not been established, as yet, because 
of lack of opportunities to investigate the disease 
in a large survey. The results obtained with the 
blastomycin skin test are not as consistant as skin 
tests for histoplasmosis or coccidioidiomycosis. 
The test is negative in the earliest stages of the 
disease, in mild localized cutaneous cases, and in 
the overwhelming or terminal phases when anergy 
occurs. An important misleading factor is the oc-
currence of cross-reaction with histoplasmin, coc-
cidioidin, and the antigen of Blastomyces brasili-
ensis (119), which are apparently due to a common 
antigeno Cross-reactions between histoplasmin and 
blastomycin are frequent. To some extent mistakes 
of interpretation arising from these cross-reactions 
are lessened if coccidioidin, histoplasmin, and 
blastomycin skin tests are performed simultaneously 
on all patients suspected of these mycotic infections 
because the skin reactions to homologous antigens 
are more pronounced. 
(5) Complement fixation test: the sera of patients with 
blastomycosis are able to fix complement with sus-
pensions or extracts of B. dermatitidis used as anti-
gens (120}o Like a positive blastomycin skin test, 
a positive complement fixation test is only of pre-
sumptive value, but it has been found useful in 
detecting cases and spurring greater efforts aimed 
at more definite diagnosis by demonstration of the 
organism through mycologic or histopathologic studies. 
The complement fixing titer is generally negative or 
low in early, mild or subclinical infections, or in 
well localized cutaneous blastomycosis (121). The 
presence of a high antibody titer in the complement 
fixation test is an indication of a poor prognosis 
for the patient. Martin (120,122) has emphasized 
the importance of a~equate serologic tests on patients 
with deep mycotic infections. He advocates the de-
sensitization of hypersensitive patients before therapy, 
especially iodide therapy, is started. The suggestion 
was made that iodide therapy in hypersensitive patients 
causes a further extension of the disease, presumably 
due to an acute inflammatory process, with hematogenous 
spread of the organisms to other parts of the body. 
Fe Treatment. Untreated cases of cutaneous or systemic 
blastomycosis ordinarily do not spontaneously regress. The 
cutaneous lesions have been treated with many therapeuticprepar-
ationso Iodides appear to be the drug of choice. Pulmonary or 
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systemic blastomycosis has been treated with iodides with 
variabl~ success. The diamidines, especially stilbamidine, 
has been reported by Schoenback, et alo, (123) and others 
(124-134) as useful in experimental and human blastomycosis. 
However, the number of human cases treated with the aromatic 
diamidines has been small. Final conclusions concerning the 
therapeutic value of this product in the treatment of blasto-
mycosis awaits further extensive clinical evaluation. 
IV. Bacterial ~ Fungal Polysaccharides 
A. Introduction~ The name polysaccharide implies a long 
chain molecule containing more than four molecules of simple 
carbohydrates 0 Burger (135) has further characterized these 
substances as: soluble in water, thermostable, impervious to 
the action of trypsin and urease, non-dializable, precipitable 
by acetone, ether and alcohol. 
B. Methods of isolating bacterial polysaccharides. 
Heidelberger, and associates, have published a series of 
studies (136-140) on the isolation of polysaccharides from 
Mycobacterum tuberculosis varieties human and bovis, and 
Diplococcus pneumoniaeo The method devised by these invest-
igators was based on the principle that the polysaccharides 
should be extracted in such a manner that the least amount of 
physical change should occur. They believed that even though 
the polysaccharides were heat stable and could be precipitated 
by strong chemicals that these methods caused distortion of 
the chemical configuration of the polysaccharide, therefore, 
they were not antigenically similar to the native polysac-
charide. Their method makes use of the precipitation of the 
polysaccharide by alcohol, care being taken to keep the prep-
aration at refrigerator temperatures~ This method has become 
the basis for the extraction of polysaccharides from many 
bacteria and fungi. 
Raistrick and Topley (141) and Palmer and Gerlough (142) 
have reported the isolation of polysaccharide substances from 
Salmonella, using 80 per cent phenol. The dried organisms 
were suspended in the phenol. This mixture was centrifuged 
and the supernate decanted. The cellular debris was treated 
several times with phenolo The supernates from these extrac-
tions were pooled and ethanol added. This procedure precip-
itated the polysaccharides. The phenol (infinitely soluble 
in alcohol) remained in the alQohol. These authors reported 
that immunization with 4 x 10-"/mg of Salmonella polysaccharides 
protected 50 per cent of 88 mice when they were challenged with 
5 x 104 organisms. The phenol extraction method has been used 
by Nicholes (143) and Alexander, Wright and Balwin (144) for 
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the extraction of polysaccharides from Pasteurella tular-
ensis.Oeding (145) compared various methods of isolating 
polysaccharides. He concluded that, with Staphylococcus 
aureus, formamide extraction at l500 C produced the greatest 
yield of polysaccharide. Vogel (146) autoclaved broth 
cultures of Candida albicans and isolated serologically 
active polysaccharides. 
c. Methods of isolating fungal polysaccharideso The 
apparent lack of specificity and sensitivity of histo-
plasmin, blastomycin, and coccidioidin has been the stimulus 
for investigators to search for a more efficacious diag-
nostic substance to be used for the detection of deep my-
cotic infections. 
Hirsch and Benson and Hirsch and D'Andrea (147-149) 
isolated, by electro-dialysis, a polysaccharide-like sub-
stance from filtrates of Coccidioides immitis. Using this 
substance they were able to produce skin reactions in 
patients with coccidioid.omyc osis infections. Van Pernis, 
~ ~., (150) using acetone, precipitated a polysaccharide 
substance from histoplasmin. This polysaccharide produced a 
skin test reaction in persons known to be infected with 
H. capsulatum. 
Hassid, ~ al., (151) isolated a polysaccharide from 
coccidioidin. They precipitated the polysaccharide with 
alcoholo When hydrolyzed, this polysaccharide yielded 
galacturonic acid and glucose. Peck, Martin, and Hauser 
(152) obtained a polysaccharide from both the mycelium and 
broth filtrate of Bo dermatitidis. They employed alcohol 
precipitations and obtained, from the broth filtrate, a 
0.01 per cent yield. A 0 0 7 per cent yield of polysaccharide 
was obtained from the cellso The antigenic relationship of 
these polysaccharides was not studied. Using these substances 
they were able to produce typical skin reactions in the 
forearms of two patients with blastomycosis. Scheff (153) 
employed Heidelberger's methods to obtain a polysaccharide 
from the mycelial phase of Ho capsulatumo He reported 
that the polysaccharide produced stronger reactions than. did 
the protein fraction, when these substances were employed 
for skin tests of animals. Cross and Howell (154) treated 
histoplasmin and blastomycin with the chemical methods of 
Peck, et alo, (152), and obtained a polysaccharide from each 
of these substances. In a preliminary report these investi-
gators stated the hypothesis that with critical concentrations 
of the polysaccharide, a specific skin reaction could be ob~ 
tained despite the cross~reactivity noted when larger amounts 
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of the test substances were used as skin test antigens. 
However, no experimental evidence to support this view has 
been presented. Hill (155) modified the methods of Heidel-
berger and obtained a polysaccharide from the yeast phase 
of H. capsula tum. He reported that a positive skin re-
action was induced by this substance in H. capsulatum in-
fected guinea pigs. Dyson, ~ al., (156T reported the 
isolation of polysaccharides from the filtrates and yeast 
phase cells of H. capsulatum and B. dermatitidis. These 
workers used sodium acetate, acetic acid and alcohol to 
precipitate the polysaccharides. They had the impression 
that a better skin reaction was obtained from the filtrate 
polysaccharide than from material obtained from cells when 
these were injected into rabbits. 
K~TERIALS· AND METHODS 
I. Strains of Fungi Investigated 
The production of pO~'Ysaccharide capsular material is 
known to influence the pathogenicity of some micro-organisms, 
such ~s Diplococcus pneumoniaeo The possibility of dif-
ferences in the nature and amount of polysaccharides in 
Ho capsulatum and g. dermatitidi.s was considerea as a cor-
ollary of this investigation. Three strains each of these 
fungi, of known mouse virulence, were chosen as· t~e org~n­
isms for investigationo The following strains of H. cap-
sulatum and Bo d'ermatitidis were used: 
H. capsulatum, strain G17, was received from C. C. 
Campbell, Army Medical School, in May, 1950. This strain 
was isolated from a fatal case at Walter Reed Hospital. 
The LDSO for mice by intravenous ghallenge with yeast phase 
organisms is approximately 1 x 10 (47). 
H. capsulatum, strain G17(M), was isolated from ~ super-
ficial infection of the finger of a laboratory worker in the 
Department of Bacteriology of the University of Utah. The 
LD50 fo~ mice by intravenous cha15enge with yeast phase organisms is,approximately 1 x 10 ~ 
Bo capsulatum, strain 6651, was obtained from Dr. C. W. 
Emmons of the National Institutes of Health. The LDSO for 
mice by intravenous challenge with yeast phase organisms is 
approximately 4.5 x 100. 
B. dermatitidis, strain 410, was obtained from Dr. M. 
Littman, Tulane University in December, 1949. The organism 
was originally isolated from lung tissue of a pneumonectom-
ized patient in 1948. The LD50 for mice by intravenous 
challenge with yeast phase organisms is approximately 170 
"population unit~" (58). 
Bo dermatitidis, strain 380, was obtained from Dr. M. 
Littman, Tulane University. This organism was originally 
isolated from a fatal case in 1947. The LD50 for mice by 
intravenous challenge with yeast phase organisms is greater 
than 1000 "population units." 
B. dermatitidis, strain 6052, was obtained from Dr. C. 
W. Emmons, ~ational Institutes of Health, in 1956. The LD50 
for mice by intravenous challenge with yeast phase organ-
isms is greater than 1000 "population units." 
Polysaccharides were extracted from each of these three 
strains of Ho capsula tum and lie dermatitidis. 
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110 Study of Media for the Growth Qf H. capsulatum and 
B. dermatitidis. 
-The studies of Hill (155) revealed that H. capsulatum 
grew, in the yeast phase, in an enriched tryptose phosphate 
broth. The growth of B. dermatitidis in this medium had 
not been determined. An objection to the enriched tryptose 
phosphate broth might be that the medium could contain . 
polysaccharide substances. The growth of H. capsulatum'and 
B. dermatitidis in the chemically defined medium of Smith 
14) and the enriohed tryptose phosphate broth were compared. 
It was observed that the chemically defined medium produced 
scant granular growth, while the enriched tryptose phosphate 
broth produced abundant yeast phase growth. Although the 
enriched tryptose phosphate broth contained a small amount 
of non-antigenic polysaccharide, it was found that the 
superior growth of yeast phase organism was necessary for 
the production of the maximum amount of skin test active 
polysaccharide. Thus, the medium used throughout this in-







Tryptose phosphate broth • • • 29.5 g 
Yeast extract • • • • • • • • 4.0 g 
. -
Maltose .. ~. • • • • • • • • • 10.0 g 
Cystine • • • • • • • • • • • 0.5 
Distilled water • • • • • • • 1000 
Initial pH • • • • • • • • •• 7.4 
pH after autoclaving • • • •• 6.8 
g 
ml 
The following procedure was utilized for the growth 
of each of the three strains of H. capsulatum and B. derma-
titidis. Seed cultures of the strain of fungi under in-
vestigation were prepared by the inoculation of 10 ml amounts 
of the enriched tryptose phosphate broth. This culture was 
incubated at 37°C until heavy grow~h of yeast phase organisms 
was apparent; that is, about one week. Microscopic examina-
tion of the cultures was then employed as a control designed 
to reveal only yeast phase fungi and no contaminating bact-
eria. The seed cultures were inoculated in 1 ml amounts 
into each of 6 low form flasks. Each of these flasks con-
tained 1 liter of the enriched tryptose phosphate broth. 
The low form flask cultures were placed on a slowly moving 
mechanical shaker and incubated at 370 C. After approxi-
mately 7 days gross and microscopic examination of the 
material in each flask revealed a heavy growth of yeast 
phase organisms without bacterial contamination. The organ-
isms growing in each flask were killed by the addition of 
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1.0 percent (final concentration) formalin. After 2 days 
additional incubation, tests for viable fungi were made 
by the inoculation of 1 ml from each of the flasks into 
50 m1 of the original type of broth. These tubes were 
incubated for 2 weeks before being discarded. 
The yeast phase cells were separated from the broth 
by filtration through a Seitz filter. The cells were 
harvested from the filter pad and resuspended in 200 ml 
of·saline, and then ground in a ball mill at 40 C for 3 
days. Frequent microscopic examination of the ground cells 
revealed that maximum rupture of the cells occurred within 
3 days of grinding. The ground cells were centrifuged to 
remove the cellular debris and the cell free extract of 
supernatant fluid was used for chemical extraction of the 
polysaccharide substances. The 6 liters of filtered broth 
(histoplasmin) were poured into dialysis tubing. Evapor-
ation of water on the outer surface of this semipermeable 
membrane was used to concentrate the 6 liters of filtrate 
to 690 ml of concentrated histoplasmin. 
Mycelial phase organisms of H. capsulatum, strains 
G17, G17(M) and 6651, were grown in the tryptosebroth for 
60 days at 200 C. The histoplasmin and mycelial mat were 
used as additional sources for the extraction of polysac-
charides. 
III. Methods of Extracting Polysaccharides 
The cell free extracts and concentrated histoplasmin 
were treated by the polysaccharide extraction method of 
Heidelberger, et al., (136-140). This method was modified 
by local qircumstances; essentially, the procedure consisted 
of the f6llowing steps: 
A. Sodium acetate is added to a final concentrat.ion 
of 10 per cent. Acetic acid is added to adjust the pH to 
5.0 and 2.5 volumes of cold 95 per cent ethanol is then 
added slowly. The resulting precipitate is allowed to 
settle overnight in the refrigerator. 
B. The supernate is decanted and the precipitate dis-
solved in 250 ml of 10 per cent aqueous sodium acetate, 
pH 5.0. . 
c. To the "2.5 volume supernate" is added 10 per cent 
sodium acetate and an additional 2.5 volumes of cold 95 per 
cent ethanol. The resulting precipitate is allowed to 
stand overnight in the refrigerator and then "treated as in 
step B. The polysaccharide obtained was called the "5 volume 
precipitate." 
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D. The fluid separated from the "5 volume precipitate" 
was further treated with sodium acetate and 5 volumes of 
cold 95 per cent ethanol. The fesulting precipitate was 
then treated as described in step B. This precipitate was 
called the "10 volume precipitate." 
E. Protein is removed from the aqueous polysacchar-
ide fractions by the chloroform extraction method of Sevag 
(157). This method consists of the addition of an equal 
volume of chloroform to each aqueous polysaccharide fraction. 
The chloroform causes the protein to precipitate at the 
interface between the chloroform and the aqueous solution 
of polysaccharide. The aqueous polysaccharide fraction is 
separated and the protein chloroform mixture discarded. 
The usual experience was that 6 chloroform treatments re-
sulted in no further appearance of precipitate at the in-
terface. After removal of the protein, these fractions 
were dialyzed against daily changes of distilled water 
until sodium ions could not be detected in the dialysate 
by flame photometery. The dialyzed fractions were filtered 
through Seitz filters, and precipitated with an equal volume 
of anhydrous ethanol. The resulting precipitates were col-
lected in tared weighing vials and dried in vacuo. The total 
weight of dried polysaccharides was obtained for each fraction. 
Subsequent studies of the skin test activity of the 
2.5, 5, and 10 volume precipitates, showed each' 'of these 
fractions to be of equal antigenic activity, the~efore, in 
the definitive investigations the total polysaccharide 
content was precipitated by the addition of 10 volumes of 
c old ethanol. 
The polysaccharide method outlined in the previous 
paragraphs, produced good yields of polysaccharides from 
the histoplasmin, but lesser yields were obtained from the 
cell free extracts. Investigation of two other methods of 
polysaccharide extraction were attempted to determine if 
some other method would produce greater yields of polysac-
charide from the cellular material. 
A saline suspension of cells of H. capsulatum was auto-
claved at l210 C for 10 minutes. The coagulated protein was 
separated from the heat stable polysaccharides by centrifu-
gation. The supernatant polysaccharide solution was re-
moved and the protein debris washed twice wi'th sodium acetate 
solution, pH 5.0. These washings were added to the super-
natant solution and the polysaccharides precipitated by 
the cold ethanol process outlined previously. 
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Two hundred m1 of a saline suspension of li. capsu1atum 
cells were dissolved in 500 m1 of an 80 per cent phenol 
solution. The mixture was shaken and placed in the refrig-
erator overnight. The cellular elements were separated by 
cent~ifugation. Microscopic examination of the cellular 
debris revealed that approximately half the cells were 
still intact. Two more phenol extractions were necessary 
before all of the yeast cells were ruptured. The super-
nates from the three extractions were poo1edan~ 2.5 volumes 
of cold 95 per cent ethanol was added to precipitate the 
polysaccharides. These polysaccharides were then purified 
using the method of Heidelberger (136-140) as previously 
described. 
IV. Methods for the Chemical 'Characterization of H. ~ 
sulatum and B. dermatitidis Polysaccharides 
A. Paper Chromatography. Paper chromatographic 
methods are of great value in the analysis of carbohydrate 
constituents of polysaccharides. Procedures have be~n 
described which enable an investigator, by means of one 
or two dimensional paper chromatograms, to separate the 
uqit constituents of polysaccharides. In general, the 
pd1ysaccharides are first hydrolyzed and the hydro1ysates 
are treated as mixtures of monosaccharides. The reducing 
properties of most monosaccharides has been used as the .. ~' 
basis for the development of specific colors on the 
chromatogram. 
The following method was used to determine the carbo-
hydrate nature of H. capsu1atum and B. dermatitidis poly-
saccharides: 
(1) Hydrolysis of the polysacchari~des. Miya (158) 
has investigated the conditions necessary for 
optimal hydrolysis of polysaccharides. He con-
cluded that the greatest yield of monosaccharides 
was obtained by hydrolyzing with 6 N HCL for about 
6 hours, followed by neutralization with barium 
carbonate. Twenty m1 (20 mg/ml) of H. capsu1atum 
and B. dermatitidis polysaccharides were hydro-
lyzed by this procedure. 
(2) The chromatogram. The neutralized (pH 7.0) hydro-
lysates were spotted, in~2 m1 amounts, 6 cm from 
the bottom of Whatman #1 filter paper strips . 
(30 x 45 cm). Equal amounts of xylose (pentose), 
dextrose (hexose) and maltose (disaccharide) were 
spotted, as controls, on each chromatogram. A 
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large glass tank (5Ocm x 20cm x 40cm in dimen-
sions) was used as the chromatographic chamber. 
The inside of the tank was lined with large 
sheets of filter paper, so that ,~he area within 
the tank was ,saturated with the solvent. An 
ascending type of procedure was utilized, there-
fore, the filter paper'sheetswere lowered into 
the tank and suspended so that the bottom of the 
filter paper was in contact with the butanol, 
acetic acid and water (40;20:22) .solvent. The 
lid of the tank was sealed to produce an air 
tight chamber and the tank was placed in the 
refrigerator to avoid temperature variations. 
The solvent then moved up the paper by capillary 
attraction carryi~g the carbohydrate test sub-
stances and controls. The distance these sub-
stances move up the paper depends on the size and 
mobility of the molecules. The solvent front 
usually reaches the top of the paper in 72 hours. 
(3). The development of carbohydrate colors on the 
chromatogram. The chromatograms were removed from 
the tank and dried a~ room temperature. The ~tand­
ard method for the development of reducing sugars 
on a chromatogram is the spray application of 
silver nitrate. Silver nitrate reacts with the 
reducing substances to produce black silver oxide. 
Excess silver oxide can be removed with sodium 
thiosulfate (x-ray film fixer) however, some con-
stituents of the filter paper also react with 
silver nitrate. This lack of specificity made the 
procedure unsatisfactory. The monosaccharide 
color developing method of Stattler and Zerbon (159) was investigated and found to be specific 
for pentose (xylose) and hexose (dextrose) sugars. 
This method of color development was utilized, 
the following is essentially the procedure: the 
dried chromatogram is sprayed with a 0.3 per cent 
solution of para-amino hippuric acid which is 
dissolved in 70 per cent ethanol. After lightly 
spraying, the chromatogram is dried in an oven at 
1400 C for 8 minutes. This procedure seems to 
selectively bind the para-amino hippuric acid to 
the hexose and/or pentose in such a manner that 
resonating bonds are produced. These bonds then 
fluoresce when exposed to ultraviolet light. All 
of the monosaccharides and to a lesser extent the 
disaccharides fluoresce when subjected to this 
treatment. Pentoses produce a visible pink color 
when tested by this method and appear to fluoresce 
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more intensely than do equal amounts of other 
sugars. The ,polysaccharide hydrolysates and 
controls on each chromatogram were developed 
by this method. A comparison of the position 
of the spots of unknown (hydrolysate) and 
control preparations was made by measurement 
of the distance each ascended the paper. 
" 
B. Spectrophotometric Determination of the Pentose 
and Hexose content of H. capsulatum and B. dermatitidis 
Polysaccharides. D~sche and ShettleSllbO) have reported 
a method for the quantitative estimation of hexose and/or 
pentose content ·of polysaccharide solutions. The test is 
performed in the following manner: 
(1) A solution of 1 part water ~and 6 parts concentra-
ted sulfuric acid is prepared. 
(2) A 0.3 per cent solution of cysteine is prepared. 
(3) To tubes containing 1 ml of specimen, immersed 
in an ice bath to prevent excessive heating, are 
added 4.5 ml of the "sulfuric acid reagent. After 
dissipation of the heat, the tubes are removed 
from the ice bath and allowed to ~ome to room 
temperature. 
(4) Subsequent heating of these acid carbohydrate 
solutio'ns for 3 minutes or 10 minutes produces 
two distinct absorption patterns. However, 
heating for 10 minut~s may result in carmeliz-
ation of the sugar solution and interfere with 
the absorption spectrum; therefore, the tests 
in this work were heated for 3 minutes. 
(5) After heating and cooling, 0.1 ml of the cysteine 
solution is added to each tube. A greenish yel-
low color develops within a few minut~s and 
remains stable overnight. 
(6) The absorption spectrum is determined for each 
specimen in a Beckman model D.U. spectrophoto-
meter. 
(7) One rnl of the following solutions was tested: 
a. 10.0 mg per cent dextrose 
b. 5.0 mg per cent dextrose 
c. 2.5 mg per cent dextrose 
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d. 5.0 mg per cent rhamnose 
e. 5.0 mg per cent of unknown H. capsulatum or 
B. dermatitidis polysaccharides 
f. H20 blank 
C. Other Chemical Determinations 
(1) Reducing substances, as a measure of true 
dextrose, were determined by the standard 
clinical Folin Wu technic, as outlined by 
Fester (161). 
(2) Nitrogen content of the polysaccharides was 
determined by the micro-Kjeldahl procedure. 
(3) The phosphorous content of each polysaccharide 
was determined utilizing the method outlined 
by Fester (161). . 
(4) Certain other standard qualitative tests for 
carbohydrates, that is, Molisch and iodine 
tests were performed. 
(5) Qualitative biuret tests were performed for 
the detection of protein in each polysaccharide 
preparation. 
v. Serologic Procedures 
A. The Oudin and Ouchterlony Methods. The formation 
of visible antigen-antibody precipitates in agar is a simple 
yet highly sensitive method for the determination of homo-
geneity of serologically active substances. Experiments 
were performed by the modification of the Ouchterlony .pro-
cedure described by Halbert, Sweck and Sonn (162). Agar 
plates were prepared by pouring 0.6 per cent barbital buffer 
agar into clear petri dishes. These plates were incubated 
at 370 C for 24 hours to remove excess moisture. After the 
moisture had evaporated, a central well and 3 or more peri-
pheral wells were made utilizing a steril~ cork borer about 
8 mm in diameter. After exploratory efforts, the first 
definitive experiment was conducted as follows: diphtheria 
antitoxin was placed. in the central well and the following 
antigens were placed in the outer wells: diphtheria toxin, 
normal serum and saline. Duplicate plates were inc·ubated 
at 200C for 14 days before the precipitates were clearly 
visible. 
Other experiments were performed to observe the re-
actions of blood group A and B polysaccharide substances 
with anti-A serum. Triplicate plates containing anti-A 
serum in the central well and the A and B substances and 
a saline control in the outer wells were incubated at room 
temperature, in the refrigerator or at 370 0 for one month. 
A third series of experiments involving the extracted fungal 
polysaccharides were carried out as follows: anti H. cap-
sulatum serum, prepared by the injection of rabbits with 
yeast phase cells was placed in the center well. The fol-
lowing He capsulatum antigens were placed in the peripheral 
wells: 
(1 ) H. capsula tum strain G17(M) broth polysaccharide, 
2 mg/ml. -
(2 ) H. caEsulatum strain G17(M) cell polysaccharide, 
"2 mg/ml. ; 
(3 ) H. capsulatum broth filtrate (histopla~min) 
undiluted. 
(4) H. capsula tum strain 6651 broth polysaccharide, 
"2 mg/ml. 
(5) Ho capsulatum strain 6651 cell polysaccharide, 
2 mg/ml. 
(6) Saline control. 
Triplicate plates were prepared and sealed. One plate 
was incubated at 370 C, another at 200 0 and the third at 40 0. 
~thenever the wells were empty, the contents were replaced. 
The tests were incubated for 14 days before precipit~tes 
were clearly visible and unchanging. 
A fourth experiment was conducted using the Oudin agar 
precipitation technic. A portion of the same anti H. cap-
sulatgm serum used in previous experiments was diluted 1:2 
with buffered 1.2 per cent agar. While the agar was still 
liquid, 2 sets each of 6 precipitin tubes were half filled 
with the agar-antiserum mixturee When the agar had solidi-
fied, the following amounts of H. capsulatum G17(M) broth 
polysaccharide contained in 0.5 ml of saline were added to 
duplicate tubes: 265 mg, 1025 mg, 0.62 mg, 0.31 mg, 0.15 mg 
and saline controle These tubes were sealed; one set was 
incubated at 370C and the other set at 2000 for 1 month. 
Another experiment, the fifth in the series, was per-
formed to investigate the cross re~ctions .of H. capsulatum 
strain G17(M) polysaccharide with Co immitis, B. dermatitidis 
and Ho caTIsulatum antiserao In the center well of each of 
three a'gar pfates was placed the following concentrations 
of lio caj2s,.:.ula_t,urn strain G17 (M) polysaccharide: 50 0 mg/ml, 
205 mgTml and 1&25 mg/mlo The outer wells of each plate 
received the rabbit antisera and a saline controlo Dupli-
cate tests were incubated for 20 days at 200 C before the 
results were clearly apparento 
The sixth experiment was performed to compare the 
reactivity of a cell free extract (CFE) of Ho ca"Qsulatum 
strain G17 (M) and Ho ~.ru2~~1tl.§tt1!m strain G17 (M) polysaccharide 
against lio ~53.t'4!!! antiserumo The center wells of dupli= 
cate plates were charged with the antiserumo One of the 
outer wells received CFE and the other peripheral well re-
ceived the polysaccharideo These duplicate plates were 
incubated for 13 days at 2000, after which the lines of 
precipitate were unequivocal and unchangingo 
The seventh experiment was performed to investigate 
the agar precipitation reactions of gui.nea pig sera known 
to contain complement fixing antibodieso Seventeen guinea 
pig sera containing complement fixing antibody were tested 
against He Q,@su~:,,~tum strain G17(M) polysaccharidee The 
17 guinea pig sera, positive and n~gative control sera and 
saline were placed in groups of 5 on the 4 plateso The test 
was prepared in duplicate and the plates incubated at 200C 
for 20 days before the precipitation lines were clearly ap-
parent and unchangingo 
The eighth experiment in this series was performed to 
investigate the cross reactions of Ho cgpsulatgm strain 
G17(M) polysaccharide with pneumococcal capsular antiserao 
Types 1 through 32 pneumococcal typing sera (Wyeth, lot 35R) 
were placed into the peripheral wells on 6 agar plates, 
while the central cell of each plate was filled with Ho cap .... 
s:ulatum strain G17(M} polysaccharideo, Due to the limited 
supply of the pneumococcal antisera this test was not run 
in duplicateo The plates were incubated at 200 C for 20 dayso 
The ninth experiment was designed to determine the 
agar plate reactions of thr'ee strains, of Bo ~rm9tit:ldi§, 
polysacc,harlde with ],0 de~!!l,atitilli ant:iserum which was 
placed in the center wel10 The following strains and con""" 
c entrations of B 0 d~r'mg_JL~;~tJ~<i:is polysaccharides were plac ed 
in the 4 peripheral ~el1s: 12,0 de:rmatitidis,' strain 380 
poly~acchc:ridej, 2 mg/ml; Bo 0 d.~:r:,r,;tatitid~s ~train 410 polysac-
charlde, :2 mg/ml; B 0 d_erIf1a~:!~,1Ql.S straln b052~ 2 mg/ml and 
blastomycin (broth filtrate undiluted)o This test was set 
up in duplicate and incubated at 200 C for 20 days before 
precipitates were definablso 
The tenth experiment was performed to investigate the 
cross reactivity of B,£, dermatitidis polysaccharide with 
.Q.o immitll9 Jj,o Q,.apsu1s1.1!m and Bo dermatitidis antiserao . 
The 120 a~,§.titidis strain 410 broth polysaccharide, 2 mg/ml, 
was placed in the center well, while the fungal antisera 
and a normal serum were placed in the 4 outer wells o This 
test was set up in dupl e and incubated at 200 C for 20 
days before the results were clearly apparento 
Bo Complement Fixation Methodso Smith has emphasized 
the value of the standard Kolmer complement fixation test 
in the 1aboratory diagnos of coccidioidomycosis (164)0 
In this investigation the Kolmer complement fixation test 
was used ( ) 0 
Complement titrat complement was titrated by 
adding 100. 105, 20 0, 205 and 3 0 0 ml of a 1:50 dilution of 
pooled guinea pig serum in Kahn tubeso The volumes were 
equalized with buffero Amboceptor, which had been pre-
viously titrated, 1 0 0 ml of a 1:1000 dilution and 0 0 5 ml 
of a 2 per cent suspension of sheep red blood cells were 
added and the volume of each tube was equalized with buffered 
salineo The tubes were placed in a 37°C water bath for up 
to 60 minuteso One unit of complement was taken as the least 
amount that gave "sparkling!! hemolysiso The dilution of com-
plement that was used in the tests was calculated to contain 
2 units in 1 0 0 mlo 
Antigen titrationg 'the capacity of the capsulatY!!! 
and B 0 g.~..r!!!S!:i ~idif! polysaccharides as complement fixing 
antigens was unknown~ therefore, optimal dilution antigen 
titrations were designedo The antigenic unit was considered 
to be the t concentration contained in 0 0 5 ml which gave 
complete ion with the smallest amount of antiserumo 
The optimal dilution of antigen in every case was found to 
have no determinable anticomplementary activi'tyo The titra-
tions were set up using 005 ml of serial dilutions of antigen 
and antibodyo Two units of complement were added and the 
system was kept overnight at 50 0 0 Hemolysin, IflOOO and the 
2 per cent suspension of sheep red blood cells were then 
added in 0 0 5 ml amounts of each 0 The tubes itiera incubated in 
a water bath at 37°C until controls cleared, usually within 
30 minuteso The endpoint of the test was the last tube con-
taining easily visible unhemolyzed cells, ioeo, about a one 
plus reaction in the Kolmer system (165)0 
In all t s, antigen and antibody controls for anti-
complementary activity, as well as complement controls, were 
includedo All complement, hemolysin and sheep cells were 
freshly titrated before being used in a test serieso 
Co Hemagglutination Methodso Norden (69) has reported 
that histoplasmin could be used as the antigen for hemag~ 
glutination tests with Ho capsulatum antiserumo The suit-
ability Ho capsulatum polysaccharides as hemagglutination 
antigens, was investigated using the hemagglutination pro= 
cedures of Middlebrook and Dubos (166)0 An optimal propor-
tions type of test was carried out according to the scheme 
shown in Table 10 
A control test similar to the test described in Table I 
was set up using histoplasmin adsorbed sheep red blood cells 
and normal serum controls for nonspecific agglutinations were 
includedo These tests were incubated in a water bath at 370 C 
for 2 hours and then overnight at room temperatureo The 
patterns of the red blood cells formed in the bottom of the 
tubes were noted and macroscopic agglutinations were also 
observed in the usual mannero 
VIo Skin Test Method~ 
Ao Introduc·tion: General Methodologyo A crit al ab .... jective of this investigation was to determine if a defined 
amount, by weight, of lio Q.5!,psulat!!ln and/or Bo d~ermatitidis 
polysaccharides, when injected intracutaneously, could pro-
duce a specific skin test reaction in Ho capsulatum or Bo 
dermatitid~~ infected animalso 
The guinea pig was chosen as the test animal because 
this animal is known to be susceptible to the infection 
when large inocula of the fungi are injected intraperiton-
eallyo Infected animals surviving for one month usually 
exhibit skin hypersensitivityo Albino guin'ea pigs are more 
easily observed for skin test reactions, therefore, in this 
work the test animals were albino or lightly colored guinea 
pigs() These anirnqls were injected intraperitoneally with a 
suspension of Ho c"a12§lllatl!!!l or Bo. derI.!!atitidis,o The number 
of organisms injected was estimated from hemocytometer 
countso One month after the injection, the animals were used 
for skin testso The flanks the guinea pigs were clipped 
and the area marked off as sites for the injection of the 
various antigens and controlso In all skin test experiments 
separate tuberculin syringes, fitted with 26 gauge needles, 
were used for each antigeno Bias in the observation of skin 
test reactions was lessened by random number selection of 
the syringes to used for injections into the skin test 
sites of the flanks of the guinea pigso The average diameter 
inmm of erythema and induration of each reaction was re-
corded at 24 and 48 hourso Normal guinea pigs were also 
included as controls in each experimento 
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TABLE 1 
OPTIMAL PROPORTIONS ~ HElI.tAGGLUTINATION TITRATION 
OF HISTOPLASMIN OR Ho CAPSULATUM G17(M) 
POLYSACCHARIDE AND RABBIT ANTI=HISTOPLASMIN SERUM 
Dilutions 
of antigen antiserum dilution 1: 
adsorbed to Saline 







Antigen dilutions, 0 0 4 ml, mixed 
with antibody dilutions, 0 0 4 mlo 
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In the first experiment in this series, Ho capsulatum, 
strain G17, broth polysaccharide was compared with commer-
cial histoplasmin and other Ho capsulatum'antigens o Seven-
teen guinea pigs were infected intraperitoneally with yeast 
phase Ho capsulatum, strain G170 Ten of these guinea pigs 
were alive after 1 montho The fur on the flanks of these 
animals was removed with clipperse The 15 test antigens, 
listed in Table 2" were injected intracutaneously; 8 in-jections were made in one side and 7 injections on the 
othero Three normal guinea pigs were also injected with 
these antigenso The average diameter in mm of erythema and 
edema"was recorded at 24 and 48 hourso 
The second series of experiments involved determina-
tion of the skin test reactions of polysaccharides tested 
in guinea pigs infected with either yeast phase or mycelial 
phase Ho capsula~ The animals were infected by either 
intraperitoneal or intracardial injectiono One month after 
the injection of the organisms, these animals were skin 
tested with the polysaccharides derived from the 3 strains 
of yeast phase organisms and control histoplasmino The 
amounts of the different antigens injected and the reactions 
among the animals used in this experiment are given in 
Table 130' 
The third group of experiments on skin tests were carried 
out to compare the effect on skin sensitivity of employing 
polysaccharides derived from strains of Ho capsulatum with 
different virulence characteristicso These experiments were 
designed to explore the possibility of strain differences in 
skin reactivity of the polysaccharides derived from the yeast 
phase and mycelial phase materialso The organisms, Ho cap-
sulatum, strain 6651 (low virulence), and Gl7(M) (high viru-
lence) were injected intraperitoneally into three groups, each 
containing 9 guinea pigso Two weeks after this injection, 
these animals were skin tested with the polysaccharides 
obtained from the yeast phase and mycelial phase of the three 
strains of He capsulatqIDo The skin tests were repeated again 
4 weeks 1atero Control injections of saline" National Inst 
tutes of Health histoplasmin, and a commercially available 
histoplasmin (Eli Lilly and Coo) were also employedo For 
control purposes, 3 normal guinea pigs were injected with 
these skin test antigenso 
For the fourth series of skin test experiment~, 6 mon-
keys were obtained from the University of Utah, Department 
of Bacteriology, Division of Poliomyelitis Researcho These 
animals were survivors of poliomyelitis investigations and 
were donatedo The 6 monkeys were injected intraperitoneally 
with a heavy suspension of Ho capsulatum strain G17(M)o One 
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TABLE 2 
eMETHOD FOR SKI,N frESIT'S FOR FIRST SERIES GF INVESTIGATIONS 
Antigen type Soure e Amount used 
Histoplasmin PoDo and COo* 1:100 
Histoplasmin HF16 University of Utah** 1:100 
Histoplasmin HF16 University of Utah 1:1000 
Cell polysaccharide Ho ~ a.I2sylatlJ,m, G17 
yeast phase 500 mcg 
Cell polysaccharide Ho ca12sulatum, G17 
yeast phase 0 05 meg 
Cell polysaccharide Ho ca12sulatum, G17 
yeast phase 0005 mcg 
Broth polysaccharide Ho ca12sulatum, G17 
yeast phase 500 mcg 
Broth polysaccharide Ho ca12sulatum, G17 
yeast phase 005 mcg 
Broth polysaccharide Ho capsulaturq, G17 0005 mcg 
Histoplasmin, y=l University of Utah**~~ 1:10 
Histoplasmin, y=l University of Utah 1:100 
009% NaCl control 
* Parke, Davis and Company 
** Prepared by Miss Llonas Allred, Department of Bacteriology, 
University of Utah, in 19480 
*** Prepared by Mro Gilbert Ao Hill, Department of Bacteriology, University of Utah, in 19520 This is broth filtrate from 
yeast phase growtho 
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month later the hair on both flanks of these monkeys was 
removed and 'the animala were skin t~!ted with the prepara-
tions noted in Table 170 
The next experiment (fifth) involved rabbit skin testso 
Dyson and Evans reported rabbits as suitable experimental 
animals for histoplasmin skin tests (67)0 The use of rabbits 
for skin tests offers the following advantages: (1) albino 
rabbits are more readily available than are albino guinea 
pigs; and (2) the rabbit is a larger animal a~d more skin 
test area is available per animalo In'order to further ex-
plore the feasibility of using rabbits, the following experi-
ment was performed: one albino rabbit was injected with 
Ho capsulatum, strain G17(M), in an amount calculated to be 
about an LD50 doseo One month after the injection, the fur 
on the flanks of this rabbit was removed and the test antigens 
listed in Table 18were injected intracutaneouslyo The skin 
test reactions were observed 24 and 48 hours after the in- . jectionso 
The results of skin tests described to this point 
indicated that the three strains of Ho capsulatum yielded 
polysaccharide antigens which produced specific and repro= 
ducible reactionso However, it was desirable to determine 
how a second lot of polysaccharides, extracted from each of 
the 3 strains of Ho capsulatum, would compare in terms of 
skin test reactivity with the original preparationso Further-
more, the effect of trypsin on these polysaccharides would 
yield further information concerning the possibility that 
trace amounts of protein were responsible for skin activit yo 
For this study, the sixth experiment in this series, 15 
albino guinea pigs were infected with Ho capsulatum, G17(M), 
ye~st phase organisms by intraperitoneal injectiono One 
month later, the flanks of these animals were clipped and 
the animals were tested with the antigens listed in Table 19 
The trypsin treated antigens were prepared by overnight 
cUbation at 370 0 of 5 ml of saline containing 10 mg of each 
strain of polysaccharide with .1 ml of 1 per cent trypsin 
(Difco), pH 705=8 0 0 0 
The seventh experiment in this series was. performed 
to determine the skin test activity of the polysaccharide 
extracted from Bo dermatitidis, strain 380 0 Furthermore, 
the cross reactivities of Ho capsulatum polysaccharides in 
~o dermatitidis infected guinea pigs were investigatedo 
Seven albino guinea pigs were infected intracardially 
with 1000 yeast phase Eo dermatitidis, strain 380, cellso 
After 1 month, 6 of the 7 infected guinea pigs were aliveo 
The 6 infected animals and 1 normal guinea pig were clipped 
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free of hair and the flanks used for skin testingo The 
test antigens, in the concentrations indicated in Table 21 
were injected intracutaneously into the flanks of the 
Bo dermatitidis infected guinea pigso The skin test re-
actions were measured at 24 and 48 hourso 
The eighth experiment in this series was performed 
to measure the homologous and heterologous skin test re-
actions of Ho capsulatum polysaccharides and Bo dermatitidis 
polysaccharides in 6 guinea pigs infected with Ho capsulatum 
and 6 guinea pigs infected with Bo dermatitidiso 
Six guinea pigs were infected intraperitoneally with 
yeast phase Ho capsulatum, strain G17(M} organismso Another 
group of 6 guinea pigs were infected in the same manner 
using yeast phase Bo dermatitidis, strain 410, organisms 0 
-One month after the infection of these animals, their flanks 
were clipped and 005 ml of the skin test antigens listed 
in Table 20 were injected intracutaneouslyo 
The Division of Biologic Standards of the National 
Institutes of Health has stipulated the requirements to be 
satisfied before marketing commercial histoplasmino Un-
fortunately, similar regulations for the standardization of 
blastomycin and coccidioidin have not been publishedo The 
regulations necessary for the standardization of histoplasmin 
were followed in the preparation for human use of He capsul-
~ G17(M) and Bo dermatitidis'380 polysaccharideso The 
following tests were performed to comply with the NoIoH. 
'regulations: 
(1) The Bo ~ermatitidis and Ho capsulatum polysac= 
charides, 1 mg in 1 ml, were each inoculated by 
streaking over two tubes of Sabourouds medium-o 
This concentration of polysaccharide represents 
100 times the amount injected in the skin tests o 
B& dermatitidis and Ho capsulatum polysaccharides 
'were each inoculated into duplicate tubes of 
thioglyco11ate brotho One thioglycollate and one 
Sabourouds culture from each of the two fungal 
skin test cultures was" incubated at 37°C, W'hile 
the other set of cultures was incubated at room 
temperature 0 These cultur'es were observed for 
20 days before they were declared negatiieo 
(2) Th~ same amount (1 mg/ml) of the He capsulatum 
G17(M) andi Be dermatitidis 380' pblysaccharides 
were each inoculated intraperitoneally into a 
group of 20 miceo These mice were observed for 
toxic effects and deaths o Af'ter 30 days of ob-
servation, the mice were sacrificedo Spleen and 
liver cultures,' using antibiotic blood agar were 
performed on all the miceo 
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(3) The!io capsulatum G17(M)- and Bo' dermatitidis 380 
polysaccharide solutions, in a concentration of 
10 mcg/o05 ml, were prepared and filtered throug~ 
an ultrafine sintered glass filtero Each of the 
skin test antigens was inoculated into two tubes, 
ofSabourouds and two tubes of thiog~ycollateo . 
One set of tubes was incubated at 370 0 and one 
set at room temperatureo This procedure was nec-
essary to determine the possible bacterial or 
fungal contamination of the solutions to be in-jected into humans o 
Bacterial or fungal growth was not observed on any of 
the cultures. Mouse deaths were not observed, and the 
macroscopic and cultural examination Of the mice tissue 
failed to reveal the presence of Ho capsulatum or Bo derma-
titidiso These tests were sufficient to comply with steril-
ity regulations of the National Institutes of Healtl}o The 
only other stipulation of these regulations was that the 
skin test preparation should be equal in skin reaction to. 
the standard Lot #2 NoIoH o histoplasmin, when tested in 
Ho capsulatum infE?cted guinea pigf30 The previous guinea 
pig skin tests had shown the E. ca~sulatum. G17(M} polysac-
charide to be equal to NoIoHo Lot 2 histoplasmin, while the 
Bo dermatitidis polysaccharide produced skin reaction equal 
to the only available commercial blastomycino Thus, accord-
ing to the National Institutes of Health regulations, these 
products were safe for injection into humans. 
The object of the human skin test experiment was to 
compare the reactivity of Ho capsulatum G17(M) polysacchar-
ide and Bo dermatitidis 380~polysaccharides with histoplasmin 
and blastomycino 
The skin test reactions were performed on patients at 
the Veterans Administration Hospitals, Salt Lake Cit yo A 
group of persons from the University of Utah, School of 
Medicine, also volunteered for these injections. The left 
and right volar surfaces of the forearms of each person 
were injected as follows: 
Left forearm; 
(a) upper portion 
001 ml of l~"lOO dilution of histoplasmin 
(b) lower portion 




(a) upper portion 
0 01 ml of 1-100 dilution of blastomyein 
(b) lower portion 
005 ml containing 10 meg of Eo dermatitidis 
polysaccharide 
Observati~s of the reactions were made at 24 and 48 
hours 0 The extent of induration and erythema of ~ach 
positive reaction was measured in mm and recorded. History 
of geographical areas of residence was obtained from each 
person exhibiting a reaction of 500 mm or more of induration. 
VIlo Polysaccharide Immunization of Mice 
The injection of microgram amounts of bacterial poly-
saccharides into mice, other experimental animals and man 
has produced enhanced resistance (141-144)0 Experiments 
on immunization with fungal polysaccharides have not been 
reportedo 
After a series of exploratory experiments involving 
small numbers of animals, a definitive immunization experi-
ment was performed with miceo The Ho capsulatum G17(M) 
broth polysaccharide was injected intraperitoneally into 
60 albino mice at a four day interval, according to the 
following protocol: 
IoPo Injection 





Mgo of Ho capsulatum 
polysaccharide 
A second group of 60 mice were injected intraperiton-
eally with 1 mg of Ho capsulatum G17(M) broth"polysaccharide 
at the time the 4th injection was given to the first group 
of miceo A third group of 60 mice was immunized by 2 weekly 
intraperitoneal injections of 1 ml of Ho capsulatum,G17(M) 
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whole cell antigeno A fourth group of 60 mice was used 
as non-immunized controlso Ten days after the last in-jection, the 4 groups of mice were challenged by the intra-
venous injection of 0 0 5 ml of viable lio capsulatum G17(M) 
yeast phase cellso These organisms were harvested after 
growing for 1 week on antibiotic containing blood agar 
slantso The yeast phase cells were removed from the blood 
agar slants by suspension in brain heart infusion broth. 
The number of cells in the suspension was estimated from 
hemocytometer cell countso The immunized and control 
groups of mice were diVided into 3 sub=groups of 20 and 
challenged with 1 x 10Q, 205 x lOb and 500 x 106 of Ho 
capsulatum G17(M) yeast phase organismso The deaths were 
recorded for each group of mice for 21 dayso 
EXPERIMENTAL RESULTS 
Ie Weight of Polysaccharide Extracted f£Qm He capsulatum 
and ~o dermatitidiso 
. The polysaccharide extraction method of Heidelberger, 
as described in the section on methods, produced greater 
yields than did the other methods that were employed. 
Larger yields of polysaccharide were obtained from broth 
in which the fungus was grown, than from the cellular 
elements 0 Table 3 presents a summary of the yields of 
polysaccharide extracted from each of the two species of 
fungie It is evident from Table 3 that greater quantities 
of polysaccharide were obtained from the broth than were 
obtained from the cellular material o Furthermore, 2.5 
volumes of cold ethanol precipitated the major portion 
of the Ho capsulatum and Bo dermatitidis polysaccharideso 
Although the 205 volumes of cold ethanol precipitated the 
major part of this polysaccharide, the maximum yields of 
polysaccharides were obtained when 10 volumes of cold 
ethanol were used as the precipitating agento In other 
words, there were still minor amounts of polysaccharide 
present in the ethanol broth mixture after the 2.5 volume 
of precipitate was removedo The second lots (Lot #2) of 
Ho capsulatum polysaccharides were prepared from two 
strains of Ho capsulatum by precipitating with 10 volumes 
of ethanol. The greater yields of polysaccharide obtained 
from the Lot #2 of Ho capsulatum and the Bo dermatitidis 
polysaccharides probably represents improvement in the 
technic of preparing these substances, rather than actual 
differences in the amount of polysaccharide produced by 
the two fungio 
Six liters of unseeded tryptose phosphate broth were 
treated with the ethanol extraction method used for fungal 
polysaccharide extractionso This polysaccharide did not 
produce positive skin tests in Ho capsulatum infected 
guinea pigs, even when 50 mcg were injected intradermally. 
110 Chemical Characterization of Ho capsulatum ~ Bo ~ 
matitidi~ Polysaccharides~ 
Ae Eaper Chromatographic Results o The hydrolyzed 
Ho capsulatum and Be dermatitidis polysaccharides each con-
tained one ascending migrating constituento These carbo-
hydrates, when developed into ultraviolet light visible 
spots, were in the same relative position as the control 
dextrose spots. The exact location of each spot was veri-
fied by measuring the distance each had moved up the paper. 
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TABLE 3 
WEIGHT OF POLYSACCHARIDES EXTRACTED 
FROM H. CAPSULATUM AND ~. DERMATITIDIS 
! Grams of po1v'saccharide 
Organisms r. All Broth 
2.5 v 5 v 10v 2.'5 v: 5 y 
H. ca12su1atum 
strain 
G17 0 0 0 .047 .006 I( .009)* f .0001) 
r-i 
• G17(M) .059 1.60 .013 0 
z (.001) (. 03) (.0003 ) 
+> 
0 6651 .043 0 0 • 61 0 H (.0008) (.01 ) 
\ 
G17(M) 
- - - - -
N 
- - - - -+> o • 
HO 
z 6651 











- - - - -
6052 
- - - - -
Broth control 
- - - - -
- - - - -
* ,Yield in terms of per cent, i.e., weight per 100 m1 of 
original material. 
o = no yield 






t· 21 ) .06 
5.74 (0.1) 
1.45 (.02 ) 
1:6~) 
.08 (.001) . 
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These results are illustrated in Figures 1 and 20 
pentose (xylose) showed a visible pink color which 
and was separated from the hexose by a significant 
The disaccharide control was least fluorescent and 





Bo lha Monosaccharide Content of the Polysaccharide 
Preparations. Table 4 records the negative logarithm of the 
spectrophotometric transmissions of the standards, dextrose 
(hexose) and rhamnose (pentose), and of the He capsulatum 
polysaccharidesc Figures 3 and 4 are graphic representations 
of the standard dextrose measured at 4100 AO after 3 minutes 
and 10 minutes heating with sulfuric acid. The Allen cor-
rection (167) was applied to these data to remove interfering 
light transmissionso 
Table 5 records the data from a second experiment to 
determine the hexose content of three strains of B. derma-
titidis polysaccharides. Figure 5 is a graphic representa-
tion of the standard dextrose transmissions measured at 4100 AO 
after 3 minutes boiling. Calculating from these data, the fol-
lowing amounts of hexose were present in each of the polysac-
charides: 
I. H. ca12sulatum G17 0 ., 0 • ., 0 • 0 2.19 mgjo 
2. li· capsulatum 6651 0 • ., • 0 (II • 20 07 mgjo 
3. B. dermatitidis 6052 0 0 0 0 0 I) 4.70 mgjo 
40 Bo dermatitidis 410 • 0 • e ., 41 0 4090 mg% 
50 !!o dermatitidis 380 0 0 0 0 0 0 0 4.85 mg% 
A transmission peak similar to the pentose (rhamnose) 
was not observed. It is apparent from the different trans-
mission readings for the 3 and 10 minutes tests that heating 
the polysaccharides for longer periods of time causes a 
greater hydrolysis of these substances, but this extended 
heating for 10 minutes also produces a mor~flat and less 
accurate curve for the dextrose standar~ ,( see Figure 4) 0 
Therefore, in the second series of tes€s~with the Bo derma-
titidis polysaccharides, only the 3 minute heating test was 
performed. 
C. Results of Other Chemical Tests. Table 6 records 
the results of the micro-Kjeldahl'~itrogen determinations. 
Table 7 summarizes the qualitative and quantitative data that 
40 
. Figure 1. Paper Chromatography., The fluorescent effe.ct of 











PAPER CHROMATOGRAM OF 
DEXTROSE, XYLOSE AND H. CAPSULATUM POLYSACCHARIDE 
DEXTROSE 
CONTROL 
RF = 0.235 
H.CAPSULATUM XYLOSE 
STRAIN G 17 (M) CONTROL 
HYDROLYSED 
POLYSACCHARIDE 
RF= 0.214 RF= 0.129 




SULFURIC ACID CYSTEINE TEST FOR £EXOSE AND 
PENTOSE FROM H. CAPSULATUM POLYSACCHARIDES 
. 
- Wave Len~th. An~strom Units 
--
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Test Material \D t'- 1X) 0\ 0 ........ N ('t'\ 
-::t -::t --:I-
-::t ('t'\ ('t'\ ('t'\ ('t'\ 
Dextrose 10mg% 
.065 .160 J minutes* **.030 .043 .097 .134 .148 .104 
10 minutes* .015 .022 .029 .041 .057 .068 .067 0048 
Dextrose 5 mg% 
3 minutes .023 .029 .045 .064 .087 .105 .097 .068 
10 minutes .009 .013 .019 .029 .044 .052 .051 .035 
Dextrose 2.5 mg% 
.026 0065 ; .060 3 minutes .013 .017 .039 .052 .041 
10 minutes not measurable not measurable not measurable not measurable 
Rhamnose 5 mttfo 
~. 10 minutes .047 .057 .090 .136 .151'. .106 .065 .034 
t 
.. , 
., ) ~ 
""-
.000 0000 .000 .000. .000 .000 .000 .000 B;Lank 
, 
!:!.'. c apsulatum 017 (M) 
polysaccharide 5mg% 
3 minutes .025 .024 . .(;)29 .037 .048 .052 .047 .032 
10 minutes .035 .046 .062 .085 .110 .123 .110 .079 
~ 
. 
H~ capsulatum 6651 
polysaccharide 5mg% 
.036 3 minutes .010 .013 .019 .025 .031 .031 .023 
. 10 minutes .039 .041 .050 .060 .075 .084 .072 .052 
~ Indicates time of incubation of test in boiling water 
































H. CAPSULATUM TEST 
Dextrose standard 
J minute test 
Allen correction opp/led 
• 
4--~----~--~--~~--~~--~--~~ 


















_____ ------------e .. 
Dextrose standard 
10 minute incu bofion 
Allen correction applied 
.. 
2 3 4 5 6 7 8 9 10 II 12 














B. DERMATITIDIS TEST 
./ Dextrose standard 
3 minute test 
Allen correction applied 
2 3 4 5 6 7 8 9 10 II 12 
DEXTROSE mg 0/0 
• 
TABLE 5 
SULFURIC ACID, CYSTEINE TEST FOR HEXOSE AND 
PENTOSE FROM B. DERMATITIDIS POLYSACCHARIDES 
Wave lengths. An~strom Units 
Test Material 3600 3700 3800 3900 4000 4100 4200 4300 
Dextrose 5 mg% 
3 minutes *.059 .084 .100 .149 .200 .300 .200 .149 
Dextrose 2.5 mg% 
3 minutes .067 .071 .079 .104 .136 .152 .136 .104 
B. dermatitidis 6052 
polysaccharide 5 mg% 
3 minutes .060 .079 .090 .134 .171 .280 .171 : .134 
B. dermatitidis 410 
polysaccharide 5 mg% .057 .079 .097 .130 .175 .295 .175 .130 
B. dermatitidis 380 
polysaccharide 5 mg% .043 .054 .093 .132 .173 .285 .173 .132 
Blank .000 .000 .000 .000 .000 .000 .000 .000 














KJELDAHL NITROGEN CONTENT OF Bo DERMATITIDIS 
AND Ho CAPSULATUM POLYSACCHARIDES 




380 402 402 
309 309 
3&6 306 
410 405 4,,5 
4&5 405 
400 40·0 





G17(M) 404 404 
305 305 
6651 705 706 
708 709 
608 606 
G17 904 906 
904 906 
* m.1 of 001 N HCI necessary to neutralize the ammonium 
borate for each duplicate or triplicate testo 
TABLE 7 
A SUMMARY OF SOME CHEMICAL TESTS ON 
H. CAPSULATUM AND B. ,DERMATITIDIS POLYSACCHARIDES 
! 
H. capsulatum B. dermatitidis 
strain G17{M} - strain 410 
Test Composition Composition 
Qualitative Per cent Qualitative Per cent 
Iodine neg. neg. 
Molisch pos.pos. 
,,> 
Biuret neg. neg. 
Nitrogen 4.0 4.2 
Reducing substances::>:C (6 hour hydrolysis) 90.0 75.0 
Phosphorous 1.07 0.8 
Hexose 58.8 50.0 
Pentose neg. neg. 




have been determined for the Ho capsulatum strain G17(M) 
and ~o dermatitidis strain 410 polysaccharideso The other 
strains of each of these fungi showed essentially the same 
results~ It may be deduced from these data that the poly-
saccharides are largely or entirely glucose polymerso 
The nitrogen content could represent contamination or some 
structure such as an occassional glucosamine moietyo The 
insignificant phosphorus content is most readily explained 
as contaminationo 
1110 Results of ~erologic Testso 
A. The Oudin and Ouchterlony Testso Figure 6 is a 
photograph of the diphtheria toxin and antitoxin reactions. 
The white zone around the central antitoxin well is a non-
specific reaction (also observed by other investigators) 
caused by the serumo Four lines of precipitate are visible 
between the toxin and antitoxin wells, while no precipitate 
is visible in the area between the saline or normal serum 
and the antitoxino These results have been reproduced, for 
teaching purposes, on a number of occasionso 
The second experiment failed to show precipitation be-
tween the human blood groups A and B substances and the 
anti~A seru~o This experiment has been repeated several 
times, using anti=A or anti~B serum, without visible reactions. 
No explanation is available at present for this result. 
The third series of tests involving the reaction of 
H. capsulatum polysaccharide, produced visible precipitates 
for all of the antigens, except the salineo The precipitates 
formed a white line around the center well, broken only by 
the diffusion of the salineo It is noteworthy, that the 
broth filtrate (histoplasmin) contains protein and this 
protein would be expected to diffuse at a different rate than 
the polysaccharideo However, the continuous band of precip-
itate included the broth filtrateo There are several possible 
explanations that may be offered to account for these observa-
tionso The protein may have diffused at the same rate of 
speed as the polysaccharides, or the observed reaction of the 
broth filtrate may have been due exclusively to the polysac-
charide content of the broth filtrate. The precipitate ap-
peared first opposite the broth filtrate and it was the 
widest band of precipitateo This experiment has been repeated 
and the same results have been obtainedo The experiment has 
suggested that the polysaccharide antigen contains only one 
precipitating component and that this component is the only 
visible reacting substance in the polysaccharides from the 
three strains of Ho capsulatu~~ 
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Figure 5. Diphtheria Toxin- Antitoxin Precipitation 
in agar . Four lines of precipitates in the area 
between the diphtheria toxin and antitoxin; no 
lines of precipitate opposite the saline or normal 
wells . 
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Th e t i t rat i on of the Ho capsulatum G17{M) yeast phase 
bro~h polysacchar i de by t he Oudin procedure, in the fourth 
experiment , showed a precipita te a t the interface between . 
the polysacc har i de antigen , and t he agaro Duplicate tubes, 
containing 0~ 62 mg/ml of polysaccharide, were the lowest 
concentr at i ons howi ng precipitateso It is surprising that 
a photograph of a Sa l monell a typhosa polysaccharide and 
anti - typhoid s er um, appearing in Oudin!s article, showed 
the same reaction at the interfac e wi t hout l i nes of pre~ 
c ipitate in the agar antibody mixture. This experiment has 
been repeated and t he same resul t s obtainedD The optimal 
temperat ur e f or t hese r eact ions appears to be about 200 Co 
It should be not ed that t he i ncubation times for these 
tests are pr olonged (14 days ), but onc e the reaction appears, 
it rema i ns stabl e fo r many weeks o 
The a bs ence of the c r os s r eac t ions of Ho capsulatum 
G17( M) polysaccharide wi t h other f ungal antisera are demon-
strat ed i n Figure 70 I t should be noted that the onl y 
prec i pi tat i ng band appears oppo's i te the well c ontaining the 
Ho capsulatum antiserum. 
Figur e 8 is an enlarged view of t he Ho capsulatum antigen-
antibody pr ec ipi t ate and 1 band of precipita t e is apparent. 
No vis ibl e antigen=ant i body r eac tions were apparent opposite 
the wells containing t he Co i mrnit i s or Bo dermatitidis anti-
sera o For purpos es of refer enc e , the fo l l owi ng measurements 
made in t~e exper i ments, i l l ustrat ed by Figures 7 and 8, are 
recor ded at this poi nt : 
l ~ Tot al distanc e between wel l s 0 0 0 32 mrn 
2 .. ~ Distance from c ent er well t o 
pr ec ipitate band e 0 0 .. .. .. • 0 0 22 mrn 
3 0 Time e 0 ~ 
" " 
0 
" • • 
20 days at 200 C 
A comparis on of r eactivi t y of t he li~ capsul atgm cel l 
f r ee extract (CFE ) and H ~ ca psul a tum G17 (M} pol ysaccharide 
showed t hat s ingle bands of prec i pitat e appeared at the 
same time , opposite both the CFE and the polysaccharide~ 
The following linear rel at i onshi ps, measuring from center of 
well s containing ant i gen and antibody yiel ded these results: 
l ~ CFE , total dis t anc e between wells •• 17 mrn 
20 CFE , d i s t ance from central well to 
band of prec i pitat e 0 ~ 0 .. ~ ~ 0 0 ~ 10 mrn 
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Figure 6 . Absence of Cross Reactivity of H. capsulatum 
G17(M) Polysaccharide with C. immitis, B. dermatitidis, 
and H. capsula tum antisera . 
Test 1. Center well contains 5 mg/ml H. capsulatum 
polysaccharide antigen . 
Test 2. Center well contains 2.5 mg/ml H. capsulatum 
polysaccharide antigen . 
Test 3. Center well contains 1 . 25 mg/ml H. capsulatum 
polysaccharide antigen. 
Peripheral wells contain the following antisera: 
#1 - c. immitis . 
#2 - B. dermatitidis 
#3 - M~ capsulatum 
#4 - Saline 
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Figure 7. Enlarged view of the Single Precipitating Band 
Produced by H. capsulatum strain G17(M) Polysaccharide 
and H. capsulatum antisera (Rabbit) . 
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30 Ho capsulatum G17(M) polysaccharide, 
total distance between wells e 0 0 0 0 14 mm 
40 Ho capsulatum G17(M) polysaccharide, 
distance from central well to band of 
pr ec i pit at e ()" 0 0 0 0 0 0 0 0 0 0' 0 g mm 
Time o 0 ~ 0 0 o 0 ('} o 0 o 0 13 days at 200 C 
Ho capsulatum complement fixing antibody (low titers, 
ioeo, 1:2=1:4J from infected guinea pigs failed to produce 
visible precipitates in Ouchterlony agar diffusion testso 
A known hyperimmune rabbit control serum (complement fixing 
titer 1:12g) produced a typical band of precipitate with 
the Ho capsulatum G17(M) polysaccharide antigeno 
There were no cross reactions when the lio capsulatum 
G17(M) polysaccharide was mixed with each of 32 pneumo-
coccal typing sera. 
The last two experiments involving the reactions of 
the three strains of Bo dermatitidis polysaccharides with 
Bo dermatitidis antiserum and the search for cross reactions 
of the Bo dermatitidis polysaccharid~ with other fungal 
antisera, showed reactions that were analogous to the similar 
experiments conducted with Ho capsulatum polysaccharideso 
The experiments revealed that a.specific antigen-antibody 
reaction could he demonstrated in the agar plates with the 
homologous anti=blastomyces sera and no cross reactions 
occurred using 110 capsulatum polysaccharideo In other words, 
the blastomyces polysaccharides produce a specific reaction 
without cross reactions when tested by the Ouchterlony method. 
Bo Results of Q.Qmplement Fixation Testso In this 
portion of the investigation, the complement fixation tests 
were used to determine the suitability of Ho capsulatum 
strain G17(M) polysaccharide as a complement fixing antigen 
and to investigate the correlation of complement·fixing 
antibodies present in Ho capsula~ infected guinea pigso 
Table 8 records the anticomplementary titration of the 
Ho capsulatum G17(M) polysaccharide and Table 9 records the 
res~lts of an antigenic titration of the Ho capsulatum 
G17(M) polysaccharide using known positive serum. Several 
titrations with similar results indicated that the Ho cai-
sulatum polysaccharide antigen was satisfactory for-comp e-
ment fixation testso In Table 10 are recorded the results 
of complement fixation tests conducted on sera from 25 guinea 
... '> 
TABLE 8 
ANTI-COMPLEMENTARY TITRATION OF H. CAPSULATUM 
STRAIN Gl7(M) POLYSACCHARIDE 
Antigen 
Dilution Saline 
0.5 ml 0.$5% 













* Sheep red blood cells 

















c1'H 0.5 ml 0.5 ml ::r'~ 
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COMPLEMENT FIXATION WITH H. CAPSULATUM 
STRAIN G17(M) POLYSACCHARIDE 
Antigen Anti H. cap-
Dilution sulatum*serum Complement Hemolys:in 
0.5 ml 1:2 2 units 1:1000 
, 








































* Anti H. capsulatum hyperimmune rabbit serum 
** Sheep red blood cells 
*** 4+ • 0% lysis (complete fixatiori) 
- = 100% lysis (no fixation) 
SRBC** Results 
2% 

















RESULTS OF COMPLEMENT FIXATION OF SERA FROM 





1 0 0 0 0 0 0 0 0 0 0 0 ~ 0 nego 
2 0 0 0 0 0 0 0 0 0 0 0 0 0 1:2 
3 000 0 000 0 0 000 
4 0 0 0 0 Q 0 0 0 0 000 




6 0 0 0 0 0 0 0 0 0 0 0 0 0 nega 
7 0 0 0 0 0 0 0 0 0 0 0 0 ~ nego 
$ 0 0 0 0 0 0 0 0 0 0 0 0 0 1:4 
9 a 0 0 0 0 0 0 0 0 0 0 o 0 neg e 
1:4 
o 1:$ 
10 0 0 0 0 0 0 0 0 0 0 0 0 0 
11 0 0 0 0 0 0 0 0 0 0 0 0 
12 0 0 0 0 0 0 0 0 0 0 0 0 o 1:$ 
13 0 0 0 0 0 0 0 0 0 
14 0 0 0 0 0 0 0 0 0 
15 0 0 0 0 0 0 0 0 0 
e 0 0 0 nego 
o 0 0 0 1:2 
o 0 0 0 1:2 
16 0 0 0 0 0 0 0 0 0 0 0 0 0 AC* 
17 0 0 0 0 0 0 0 0 0 0 0 0 0 nego 
1$ 0 0 0 0 0 I) 0 0 0 0 0 0 
19 0 0 0 0 0 0 0 0 0 0 0 0 
20 0 0 0 0 0 0 0 0 0 0 0 0 
QNS .. 'C .... { ., ... "I 
o AC 
o 1:128 
21 0 0 0 0 0 0 ~ 0 0 0 0 0 0 nego 
22 0 0 0 0 0 0 0 0 0 
23 0 0 0 0 0 0 0 0 0 
24 ~ 0 0 0 0 0 0 0 0 
o 0 0 0 nego 
o 0 0 0 AC 
o 0 ., 0 AC 
25 0 0 0 0 0 0 0 0 0 0 0 0 0 neg., 
Control: 
Positive serum (rabbit serum) 1:12$ 
Number poso 0., 0 0 • 
Number neg. 0 0 0 0 0 
Number unsatisfactoryo 
o 0 10 
., 0 10 
o 0 5 
':;:AC, antic omp1ementary serumo 
**QNS, quantity of serum not sufficient for test 
::::o:c,:cOne month after the Ho capsulatum infection of these 
guinea pigs, skin tests were performed and blood was 
obtained by intracardia1 punctureo 
pigs& No definite correlation could be demonstrated be-
tween complement fixing antibodies and the extent or 
severity of the Ho capsulatum infections ,in these guinea 
pigso 
It should be emphasized that the value of the poly-
saccharide as a complement fixing antigen in human histo-
plasmosis has not been investigated. Martin (118) has 
suggested that although fungal polysaccharide antigens can 
be used successfully in complement fixation with guinea 
pig sera, human anti Ho capsulatum sera do not fix comple-
ment in the presence of a He capsulatum polysaccharide 
antigen «I 
Ce Hemagglutination Testso Table 11 records the 
results of the optimal proportions hemagglutination titra-
tion of Ho capsulatum strain G17(M) polysaccharide and a 
similar titration using histoplasmin (product prepared at 
University of Utah by Gilbert Hill, 1952)0 
These results confirm the findings of Norden (69) 
that histoplasmin can be used as a hemagglutination antigen. 
Polysaccharide hemagglutination tests have been repeated 
many times since the initial positive results shown in 
Table 11 were obtained, however, none of the subsequent 
tests have been positive; therefore, the use of these 
polysaccharides as hemagglutination test antigens cannot 
currently be considered for routine use. 
IVo Results of Skin Tests. 
Ao. Guinea Pig Skin Test Reactionso Table 12 pre---
sents the results of the first series of skin tests. A 
positive skin test has been defined by early investigators 
in this field of investigation as an area of induration of 
at least 5 mm. Most of the skin test antigens used in 
this experiment produced skin reactions greater than 5 mm. 
The variations in skin test reactivity of these antigens 
are apparently due to the hypersensitive state of the 
individual guinea pigso For example, anergy of guinea pigs 
with a critical Ho capsulatum infection is well documented. 
In general, the most consistently positive and the larger 
areas of induration were obtained with the Y-l histoplasmin 
preparation of Hillo However, the Ho capsulatum G17 poly-
saccharide, in the indicated concentration, produced more 
consistent skin tests than did the commercial histoplasmin*. 
~:c Purchased from Parke, Davis and Companyo 
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TABLE 11 
OPTIMAL PROPORTIONS RESULTS OF Ho CAPSULATUM STRAIN G17(M) 
HEMAGGLUTINATION TITRATION EMPLOYING HISTOPLASMIN AND 
POLYSACCHARIDE AGAINST RABBIT ANTI-HISTOPLASMIN SERUM 
Cone entration of antiserum dilution 1: polysaccharide Saline 
adsorbed to SRBC 10' 20 40 80 160 320 640 1280 2560 5120 control 
1 mg/ml + + + + + + "'" <EO> - - -
100 mcg/ml + + + + """ .- - - .... - -








1:2 + + + "'" .... "'" <= - - - -








adsorbed to SRBC Normal rabbit 
serum 
1 mg/ml .... -= .... .... = 
500 mg/ml .... .... """ ..., <= Anti-Ho ca:Qsulatum sera 
250 mcg/ml + ... 
- "'" -














CAPSULATUM STRAIN G17 SKIN TESTS 
GUI~ffiA PIGS INFECTED WITH Ho CAPSULATUM STRAIN G17 
HF+ HF+ ~'~~~:CPo1 vsac charide 
GoP o PSS+ 16 16 PoDo + Cell mel:"!" Bl""oth,mce.' Y-1+ 
# 1:100 1:1000 1:100 005 005 500 005 005 5.0 1-10 
- :t.* 3 $ <= 10 "'" 6 4 4 12 
1. 
-
-:>:=::* 10 2 5 ... 6 12 2 
- -
"'" 
.- 6 4 ..., 4 - 5 3 10 4 20 
-
6 9 13 10 10 13 12 5 9 13 
OE> ... t. ± 
""" 
.... ... 10 
- 4 12 
3 0 
~ ..., 11 11 5 ... - 18 4 9 12 
-
... 
""" - 4 .., - <aD - 10 6 
4. 













<=> 11 2 10 15 
= ... 5 5 = 3 => 5 10 4 12 
6. 
.... 
""" 10 10 4 9 6 9 9 3 14 
Normal ... ..., - <= <=> - .... - "'" .- -
C ontroJs 
... 





+ See Table 2 for description of antigens 
* The upper number in each square indicates the average mm of 
induration measured at 24 hourso 
** The lower number in each square indicates the average mm of 
















*** Cell and broth polysaccharides extracted from Ho capsu1atum G17 
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In the second experiment the Ho capsulatum strains 
G17 and 6651 polysaccharides were tested in guinea pigs 
infected with He capsulatum G17; the results are given in 
Table 130 Reasons for the failure of the Ho capsulatum 
strain 6651 polysaccharide, in the indicated microgram 
amounts, to produce positive skin test reactions are not 
apparent 0 It is noteworthy, that 10 mcg of Ho capsulatum 
G17 broth polysaccharide produced reactions equal to the 
National Institutes of Health Lot #2 histoplasmin in the 
recommended dilution of 1:1000 These results also empha-
size the difficulties of producing consistent Ho capsulatYm 
infections in guinea pigso 
Table 14 presents the results of another experiment 
in this serieso These results are similar to those obtained 
in the two previous experimentso The skin test results 
conducted thus far i~dicated that some of the guinea pigs 
in each experiment were critically infected and anergic, 
while other animals were able to resist this infection with-
out producing skin hypersensitivityo Accordingly, a third 
series of experiments were designed to determine the effect 
of variations in skin reactivity if the route of inoculation 
is changed from intraperitoneal to intracardialo Table 15 
records the results of these testso It is apparent that 
animals infected via the intraperitoneal and intracardial 
routes reacted similarly to the injection of the skin test 
antigens 0 Furthermore, the data suggest stronger reactions 
on the part of the animals infected with mycelial material. 
In a second experiment in this third series of experi-
ments., polysaccharides extracted from the yeast and mycelial 
phases of growth of the three strains of Ho capsulatum were 
used as skin test antigens in guinea pigs infected with the 
"low virulence" Ho capsulat!!!!l strain 0651 and the "high 
virulence" Ho capsulatum. strain G17(M)o These results are 
presented in Table 160 The polysaccharides extracted from 
yeast phase organisms produced a larger area of induration 
in the skin tests, but there was no difference in the skin 
hypersensitivity of guinea pigs infected with either the 
"low virulence" or "high virulence!! organisms() 
For the fourth series of experiments involving skin 
tests on 6 monkeys, the results are listed in Table 170 
These monkeys failed to show skin reactionso Subsequent 
autopsy of these animals revealed, no gross or microscopic 
evidence of Ho capsulatum infectiono 
Table 18 presents the data that were observed when 
skin tests were performed on a rabbit infected with 
Ho capsulatumo No specific positive skin reactions were 
TABLE 13 
SKIN TESTS WITH H. CAPSULATUM STRAINS G17 AND 6651 
IN GUINEA PIGS INFECTED WITH H. CAPSULATUM STRAIN G17 
_. ;---
= 
Polvsaccharide 6651. mcg* Polysaccharide Gl.7, mcg 
GiJPo From cell From broth From broth PSS P.D.+ 
... 01 1.0 10 OJtl 1 ..• JJ 1Q (J.1 1.0 10 1:100 






~ ••• 'f, ... ,.... 
- -1. _:,;:cy.('~ 





- - - -
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- -2. 
- - - -
... 




7 10 20 
- 4 3. 
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.-
- - - - - 3 10 - -
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- - - - - - - -
14 
- -7. 





- - - 5 10 - -8. 




- - - - 4 15 - -9. 
- - -
- - - -
5 5 
- -
- - - - - - 4 6 12 - -10. 
- -
- - - - - - 9 - -
- - - - - - - - - - -11. 
- - - - - - - - - - -
- - - - - - - - - - -12. 
- - - - - - - - - - -3G.P.. _ 
- - - - - - - - - -Corrtr#Ls _ 
- - - - - - - - - -

























**Top number in each square indicates the average mm of induration observed at 24 hrs. 
*~(*Bottom number in each square indicates the average mm of induration observed at 48hrs. 
+P.D. = Parke, Davis and Company histoplasmin. 




SKIN TESTS WITH H. CAPSULATUM POLYSACCHARIDES STRAINS G17, G17(M) 
AND 6651 IN GUINEA PIGS INFECTED WITH H. CAPSULATUM STRAIN 6651 
H •. ca]2sulatum ~olvsaccharide. mc.e: 
G17* 6651':< G17(M)* 
G.P. Broth Cell Broth \ 5V Br&th 2.5V Brot.h 1,Cell NIH+ 
_#- 10 1 10 1 10 1 10 1 10 1 10 1:100 
15** 5 I 8 - - 5 - - - - - -1. 10*** 5 - - 5 - - - - - - -
2. 10 6 5 7 - - - - - - - 8 10 4 5 10 - - - - - 10 - 10 
3. 13 - - - - - - - - - - -13 3 - - 4 - - - - - - 10 
7 
- - - - - - - - - -
5 4. 
- - - - - - - - - - -
5 
10 
- - - - - - - - - - -5. 12 6 
- - - - - - - - - 5 
6. 7 - - - - - - - - - - 5 10 7 - - - - - - - - - 6 
7. 10 5 - - - - - - - - - 4· 10 6 
- - 4 - - - - - - 5 
Control - - 4 - - - - - - - - -





*G17, 6651, G17(M) indicates the strain of H. capsulatum used for 
polysaccharide extraction 
T p. +4 



































**The number in the top of each square indicates the average mm of induration 
measured at 24 hours after skin test. 
***The numbers in the bottom of each square indicate average mm of induration 
measured at 48 hours after skin test. 
+ NIH = National Institutes of Health histoplasmin Lot #2 






RESULTS OF GUINEA PIG SKIN TES~S 
GoP. Yeast ::lhase polysaccharides 
Infected . 
with G17(M) 6651 G17(M) 
H. ca12sulatum Broth Broth Ce11-s G17~M' lOmcg lOOmcg lOmcg lOOmcg lOmcg lOOmcg 
I eP.':( 
Yeast** 1067+ 7.33 2017 20 00 000 
I.C o * 
Yeast 
0 0 67 4067 0 0 83 4033 000 
I.C. 
Mycelial** 1024 12.26 000 6 0 0 OoQ 
I.Po 
Mycelial 4.00 10000 2060 806'0 000 
~C:I .P •• Intraperitoneal infection 
*IoC. • Intracardial intection 
**Yeast • Yeast phase of Ho capsulatum 












+ Each number represents the mean mm of induration obtained 
from readings made on 4-6 guinea pigs. All guinea pigs 









RESULTS OF GUINEA PIG SKIN TEST IN ANIMALS INFECTED WITH 
"HIGH VIRULENCE" AND "LOW VIRULENCE" STRAINS OF H. CAPSULATUM 
- ., ................ _., •.. , 
Guinea pigs s.s .. 665l++ S .S.G17 (M) S.S.G17 
~nfected with YP'" MJ"T" YP YP MP YP MP NIH LillJi** 
H. ca:esulatum Broth Broth Broth Cell Broth Broth Broth 
strain 71 ~OOmcg 100mcg 100mcg 100mc_g 100mcg 100mcg 100mcg 1:100 1:100 
6651 7.2* 3.0 5.0 3.5 4.0 10.0 3.8 2.9 0.5 
G17 5.0 3.0 7.2 7.2 2.8 7.0 2.8 4.6 1.0 
G17(M) 10ClO 5.0 12.0 8.0 5.0 14.0 2.0 7.2 6.2 
Mean 7.5 3.7 8.1 6.2 3.9 10.3 2.9 4.9 2.6 
Standard 
error 1.28 1.34 1.48 2.54 0.44 0.77 
-'-----
+ YP = yeast phase polysaccharide 
MP = mycelial phase polysaccharide 
++ S.S. refers to polysaccharide extracted from the three strains of fungi. 
* Mean in mm of induration observed on 5 or more guinea pigs. 










RESULTS OF MONKEY SKIN TESTS 
Six monkeys injected intraperitoneally with 
Ho capsulatum strain G17(M) yeast phase cells 
Monkey PSS *NIH **PO D6 Ho capsulatum 
polysaccharide broth 
1:100 50 meg 10 meg 100 meg 
10 






- - - - -
40 - - - .... -
50 .... 
- - - -
60 .... .... 
- - -
*NIH = National Institutes of Health Lot #2 standard histo-
plasmin 




RESULTS OF RABBIT SKIN TESTS 
Rabbit infected with Ho eapsulatum 
strain G17(M) yeast phase ceils 
Skin Test Antigen 
H. eapsulatum G17(M)·broth polysaechar~de 
( a ) 20 me goo 0 0 • 0 0 It 0 0 0 0 0 0 
(b) 200 meg 0 0 0 0 0 0 0 • ., • 0 0 • 0 
H. eapsulatum 6651 broth polysaccharide 
(a) 20 mcg 0 0 0 0 0 0 0 0 0 0 0 0 










National Institutes of Health Lot #2 histoplasmin 
(a) 1:100 0 0 • 0 0 0 0 0 0 0 • 0 • 0 • 0 -
Saline 00 •• 0.00 ••• 0 •• 0 •• II • 
-
68 
observedo Another objection to the use of rabbits was that 
the fur on these animals had to be removed by depilation 
and this procedure caused much skin irritation; in skin 
reactive rabbits, such irritation might confuse observations 
to be madeo 
In the sixth series of investigations, the effect of 
trypsin on the Ho capsulatum polysaccharide skin test 
activity and the comparison of two lots of Ho capsulatum 
polysaccharide were investigatedo These results are re-
corded in Table 190 These results revealed that the chemical 
method used for the extraction of polysaccharide was satis-
factory for the duplication of skin test active polysac-
charideso In other words, comparable skin test results were 
obtained from two separate lots of lio capsulatum polysac-
charideo These results also demonstrate that trypsin does 
not affect the skin test activity of the polysaccharide and 
is suggestive evidence that protein does not act as the 
antigenic substance in these skin testso It is also note-
worthy that 100 mcg of each polysaccharide produce uniformly 
positive skin testso 
In the seventh series of experiments the skin test re-
actions of Bo dermatitidis strain 380 polysaccharides were 
investigatedo In addit~on, the heterologous reactions of 
Ho capsulatum polysaccharide in Bo dermatitidis infected 
guinea pigs were investigatedo These results are tabulated 
in Table 20 0 The results indicate that 10 meg of Bo derma-
titidi~ strain 380 polysaccharide produced skin test reactions 
equal to or greater than the 5mm of induration chosen as the 
customarily positive reaction in guinea pigs inoculated with 
Bo dermatitidis; the polysaccharide antigen was superior to 
the sample of commercial blastomycin used for skin testingo 
A standard blastomycin is not available from the National 
Institutes of Health o 
Cross reactions were obtained with 100 mcg of Ho cap-
sulatum G17(M) broth polysaccharide when this amount was 
injected into the skin of ~o derm~titidis infected guinea 
pigso Using 10 mcg of this polysaccharide, however, in Bo 
dermatitidis infected guinea pigs, only minimal skin test 
reaction were observedo 
Further investigations of the homologous and hetero-
logous reactions of Ho capsulatum and ~o dermatitidis poly-
saccharides were conducted in the eighth series of experi-
ments and the results of these skin tests are recorded in 
Table 21 and 220 
Skin Test 
TABLE 19 
RESULTS OF GUINEA PIG SKIN TESTS 
(100 mcg of each polysaccharide) 
Comparison of 2 lots of polysaccharide and the effect of trypsin 
Normal 
Materials G17(M) Infected Guinea Pigs Controls 
NIH 1:100 10",: 8 10 12 10 12 8 5 15 15 12 15 15 10 12 
Saline 
- - - - - - - - - - - - - - -
-
6651 Lot #1 
8 Trypsin 12 10 15 12 15 10 12 15 20 10 15 20 15 15 
6651 Lot #1 10 8 12 15 12 10 10 8 15 15 15 15 15 15 15 
6651 Lot #2 
Trypsin 12 10 20 17 20 15 12 10 20 20 12 10 20 17 16 
6651 Lot #2 12 12 15 12 15 15 
-
10 15 15 15 15 20 12 18 
G17(M} Lot #1 12 15 20 22 20 15 10 15 20 20 15 15 20 20 15 
G17(M) Lot #1 
Trypsin 10 11 15 15 15 12 10 20 10 20 10 15 18 12 12 
G17(M) Lot #2 
Trypsin 15 12 20 5 10 20 12 15 10 15 18 12 12 12 10 
G17(M) Lot #2 12 15 15 12 20 20 15 15 15 20 15 15 15 15 17 
G17 11 15 20 15 15 15 15 10 20 15 17 17 lS 15 14 
,. 
~ 
* The number in each square refers to the average mm of induration observed 
24 hours after the intracutaneous injections. 
























SKIN TEST RESULTS WITH He CAPSULATUM AND Be DERMATITIDIS 
POLYSACCHARIDES IN GUINEA PIGS INFECTED WITH B. DERMATITIDIS 
Bo dermatrtidis***: Hoeapsulatum B1asto- Histo-
380 - G17(M} mvcin plasmin 
GoP. Cell Broth Broth P ()Do~o:( NIH 
10 100 10 100 10 100 1:100 1:100 
meg meg mcg meg meg mcg 
1. 10* 15 15 20 + 6 6 .." 
-
20 7 7 10 14 .... 5 - -
3. 15 20 10 17 - 4 4 -
40 7 9 6 20 5 5 .... -
50 7 15 4 10 - .... 4 t -
60 7 10 5 15 + ± 5 -"'" 
7" + oc ± ± => ... .... -Control 
*Number refers to diameter of reaction in mm (edema) 
measured at 24 hours 











SKIN TEST REACTIONS OF GUINEA PIGS INFECTED WITH B. DERMATITIDIS 
STRAIN 410: HOMOLOGOUS AND HETEROLOGOUS SKIN TEST REACTIONS 
~ .•. ---..• -..•. --..• ---- _ .................. - _. 
H.ca~su1atum H.ca12su1atum Histo- Blasto- B1asto- B1asto-
b51 - G17{MJ plasmin mycin po1y"~* po1y** G.P. 50 15 10 50 15 10 1:100 1:100 380 410 Saline 
mcg mcg meg mcg mcg meg 
1. 12* 8 4 12 6 4 - - 8 
2. 14 8 4 14 4 - - - 8 
3. 9 7 - 4 0" S 6 4 4 3 12 
4. 14 4 - 12 4 - - 3 6 
5. 4 4 3 - - - - 4 4 
6. 8 6 3 6 4 - - 3 S 
Controls 
7. 




- - - - - --
9. - - - - - - - - .-
* The numbers refer to the average mm of induration measured 

























SKIN TEST REACTIONS OF GUINEA PIGS INFECTED WITH H. CAPSULATUM 
STRAIN G17(M): HOMOLOGOUS AND HETEROLOGOUS SKIN TEST REACTIONS 
-
Polysaccharide Histo- Blasto- Blasto- Blasto-
H..caEsulatum H.capsulatum plasmin mycin poly poly 
G.P. 651 G17(M) NIH P.D.** )80 410 Saline 
50 15 10 50 15 10 1:100 1:100- 10 10 
~g ~g ~g ~g ~g ~g ~g ~g 
10 10* 5 6 9 6 5 7 4 - - -
2. 10 8 8 9 8 6 8 4 - - -
30 12 6 6 12 7 6 8 - - - -
4. 14 7 5 8 6 6 8 - - - -
5. 6 10 7 9 7 6 7 - - - -
6. 7 6 6 9 7 6 8 - - - -
pontrols - - - - - - - - - - -
* Number re~ers to the average mm of induration observed 24 hours after 
the intradermal injection. 
~o:( P. D. ;: Parke, Davis and Company blas tomyc'in 




These data show that a specific reaction can be 
elicited by the Eo dermatitidis strains 3$0 and 410 poly-
saccharide in a concentration of 10 mego The results of 
the Ho capsulatum polysaccharide skin tests reveal a degree 
of cross reaction with 10 mcg of the strain Ho caosulatum 
G17(M) polysaccharide, but these heterologous reactions 
were less than the homologous reactions and, more signifi-
cantly, they were less than the minimum reaction of 5 mmo 
Eo Human Skin Test Reactionse The human skin tests 
were conducted in the:nrnth series of experimentso In 
this investigation 134 persons were skin testedo Table 23 
shows a comparison of the histoplasmin and the Ho capsul-
~~ G17(M) polysaccharide reactionso It is noted that 
20 positive reactions were obtainedo Of these reactions, 
16 were obtained with both histoplasmin and Hocapsulatum 
broth polysaccharideo In 2 cases either polysaccharide or 
histoplasmin yielded a positive resulto Table 24 is a 
summary of the comparative reactivity of blastomycin and 
Bo dermatitidis strain 3$0 polysaccharideo The only re-
actions were apparently of a non-specific natureo Table 25 
reveals the mean mm of induration for each of the reactants. 
The results are considered in the discussi~G 
Vo Results of Mouse Immunization 
Animal losses during immunization and within 24 hours 
after the intravenous challenge reduced some of the sub-
groups of 20 mice to smaller numberso Table 26 suggests 
that some degree of protection is evidento The magnitude 
of the differences and the significance of these data can 
only be ascertained by statistical analysis, accordingly 
the data were analyzed by the method of Wilcoxon and 
Litchfield (156)0 
. Table 26 also presents the calculated LDSO values 
and the 95% confidence limits for each group of animalso 
These data indicate that there is significant protection 
,of mice immunized with either whole cells or polysaccharideo 
The LD50 of the mice receiving 4 immunizing injections of 
polysaccharide and mic'e receiving 1 immunizing injection 
of polysaccharide were so similar that no difference could 
demonstrated by the method usedo The relative efficacy of 
the immunization procedures when compared with the non-
immunized control group was further investigated by the 




HUMAN SKIN TEST REACTIONS 
Comparison of Ho capsulatum strain G17(M) 
polysaccharide with commercial histoplasmin 
Histoplasmin pOSe, Polysaccharide pOSe , 
Histoplasmin pos., Polysaccharide neg. , 
Histoplasmin nego, Polysaccharide pOSe , 
Histoplasmin neg. , Polysaccharide neg. , 
Total positive reactions • • • • • • • • • • 
Total number of tests • • • • • • • • • • 








All persons with a positive skin test have a history 
of living in an Histoplasma capsulatum endemic area. 
75 
TABLE 24 
HUMAN SKIN TEST REACTIONS 
Comparison of Bo dermatitidis strain 380 
polysaccharide with commercial blastomycin 
Blastomycin poso, Polysaccharide pos., 
Blastomycin poso, Polysaccharide neg. , 
Blastomycin nego, Polysaccharide poso, 
B1astomycin nego, Polysaccharide neg., 
Histoplasma Blastomyces 
polysaccharide pos., polysaccharide pos., 










HUMAN SKIN TEST REACTIONS 
AMONG 20 POSITIVE REACTORS 
24 hours 48 hours 
-x- mm of induration -X- mm of induration 
Histoplasmin 
Ho capsulatum Gl7(M) 
polysaccharide 
Blastomycin 








MOUSE DEATHS AND LD50 AFTER CHALLENGE WITH 
H. CAPSULATUM STRAIN G17(M) YEAST PHASE ORGANISMS 
Method of Challenge dose of 95% 
Immunization H.capsulatum G17(M) LD50 Confidence 
of mice yeas~ phase cells Limits 
lxl06 2.5x106 5.0xlO6 
~. 
Whole cell 1/16*: 2/16 9/16 8.0 x 106 15.6 - 4.1** 
4 injection 5/18 2/17 13/18 4.5 x 106 6.75 - 3.0 
po lysacc haride 
1 injection 3/12 2/12 8/15 4.5 x 106 9.0 - 2.25 p:>lys accharide 
Control 11/19 12/20 20/20 1.05 x 106 1.83 - 0.6 Non-immunized 
* Numerator = number dead; denominator::: number challenged 
** All numbers raised to 106• 
Example: 
15.6 - 4.1: 15.6 x 106 - 4.1 x 106 
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TABLE 27 
POTENCY RATIOS OF Ho CAPSULATUM WHOLE CELLS AND 





Whole cell antigen 
or 405 x 106 = 
4 injection POlYSaCCharide} 
1 injection polysaccharide 1.05x 106 4.28 
. * 8 x 106 = 
1.05x 106 
LD5~.of whole cell immunized mice. 





The 4 injection and 1 injection polysaccharide immu-
nized mice reacted equally to the challenge doses, and a 
significant degree of protection was induced. The animals 
receiving polysaccharide were able to withstand 1.76 to 10.4 
times the number of organisms which killed 50 per cent .of 
the controlso The whole cell immunized mice were able to 
receive 3.18 to l8 e 2 times more organisms than the control 
,mice. It is apparent, therefore, that the skin test poly-
saccharide preparation was able to induce a significant 
degree of protection in mice when given before the chal-
lenge dose of organisms. One immunizing injection of 1 mg 
of polysaccharide material gave protection equal to that 
obtained by 4 injections with this polysaccharide. The 
protection, while significant was apparently not as ex-
tensive as that induced by whole cell vaccine. 
DISCUSSION 
The extraction method used in this investigation 
has produced polysaccharide substances from each of 3 
strains of Ho capsulatum and Bo dermatitidiso Although 
the per cent yield of polysaccharide appears to be small 
(1 per cent or less), it should be emphasized that 
3 grams of skin test active polysaccharide, when used 
in 10 mcg doses, amounts to 300,000 skin test doseso In 
addition, the use of this method of extraction from yeast 
phase organisms eliminates the hazards of pulmonary in-
fections contracted in the laboratory that may occur when 
the mycelial phase of growth is used to produce histo-
plasmin or blastomycino There is no apparent reason why 
the methods of growth and extraction presented in this 
investigation could not be employed for the commercial 
production of fungal skin test polysaccharides. 
It is surprising that a greater quantity of poly-
saccharide was found in the broth than was isolated from 
the cellso This may indicate that the polysaccharide 
diffused out of the cells during growth, or that the 
formalin added to the culture prior to the extraction of 
the polysaccharide caused changes in the cell wall per-
meability and allowed the intracellular polysaccharide to 
diffuse from the cells into the medium. In any case, the 
data presented indicate that these polysaccharides are 
antigenic while the polysaccharide naturally present in 
the growth medium are not antigenic. 
The chemical studies of the Ho capsulatum and B. 
dermatitidis polysaccharides were not intended to be 
definitive studies to learn the structure of these poly-
saccharides; rather, they were qualitative and quantitative 
analyses designed to yield information concerning consti-
tuents and contamination of the preparationso 
The paper chromatographic procedures, using the 
para-amino hippuric acid method of developing the spots 
into ultraviolet light visible spots, provided a method 
for the separation of the polysaccharide components. The 
chromatographic results have shown that the hydrolyzed 
polysaccharide migrates up the paper essentially as one 
component and this hydrolysate appears in the same relative 
position as the dextrose controlo An example of the 
chromatograms obtained with Ho capsulatum Gl7(M) hydrolyzed 
polysaccharide has been presented (Figure 2)0 Studies of 
the other three strains of Ho capsulatum polysaccharides 
ao 
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and the Bo dermatitidis polysaccharides have produced 
similar resultsc It would be p(!fSsible to furthn.r quanti-
tate the results of the paper chromatograms by eluting 
the spots of hydrolyzed polysaccharide from the paper and 
then performing chemical analyses on the eluatesoo This 
type of proc edure is invaluable when extremely small 
amounts of the original test substance are available. 
When larger quantities of test substances are available 
it is more convenient to conduct standard macro chemical 
studies 0 For this reason, standard chemical studies of 
the constituents of the polysaccharides were conducted. 
A strictly chemical test for the determination of 
the components of the polysaccharides was the cysteine, 
sulfuric acid tests o It should be emphasized that this 
method does not yield the absolute hexose content. This 
is apparent from the fact that when the unhydrolyzed poly-
saccharides were exposed to the longer heat treatment of 
10 minutes in sulfuric acid, the results obtained sug-
gested greater amounts of hexose. Although the mechanisms 
of color development in this test have not been 'explained, 
it may be assumed that the cystiene forms some sort of bond 
with the free hexose groupings of the polysaccharide. When 
the polysaccharide is heated for 10 minutes rather than 3 
minutes, more hydrolysis occurs and consequently, more 
reactive groups are available for reaction with the cystiene 
In this investigation, there were no transmission peaks 
similar to those reported for pentose, however, 'the same 
transmission peak of 4100 AO reported by Dische and 
Shettles (160) was observed for the hexose standard and 
the Ho capsulatum and ~o dermatitidis polysaccharides. 
Calculating from these data, it was found that the B. 
dermatitidis polysaccharide contained twice as much hexose 
as the H. capsulatum polysaccharideso The difference 
between these two polysaccharides cannot be readily ex-
plained. It is evident from this study that hexose appears 
to be a major constituent of the polysaccharide. 
Other chemical studies have been conducted to further 
study the constituents of the polysaccharide. The Folin Wu 
determinations for reducing substances revealed that the 
He capsulatum and B. dermatitidis polysaccharides contain 
90 per cent and 75 per cent respectively of reducing sub-' 
stances, assumed to be dextrose (see Table 7). The small, 
but significant nitrogen content is ,envisioned as an oc-
casional glucoseamine residue in the polysaccharide moiety. 
The extremely small phosphorous content can best be ex-
plained as a contaminant. 
The Oudin and Ouchterlony agar precipitation tests 
are simple, yet effective, methods for determination of 
the antigenic homogeneity of substanceso In the first 
series of Ho capsulatum polysaccharide reactions with -
H. capsulatum, Bo dermatitidis and C. immitis antisera, 
it was shown that the [0 capsulatum polysaccharides pro-
duce one antigenic component against the hbmologous anti 
H. capsulatum serum. The B. dermatitidis polysaccharide 
showed the same specificity of reaction, that is, the 
B. dermatitidis polysaccharides produced only one band 
of precipitate against the anti ~. dermatitidis serum 
without cross reactions with other fungal antisera. These 
results are considered additional evidence that the poly-
saccharides do contain one antigenically active consti-
tuent. It is assumed, of course, that the observed 
precipitates were due to the interaction of the polysac-
charide and antiserum. The chemical studies seem to 
preclude the possibility that these antigen-antibody 
reactions were due to any substances except the poly-
saccharide. 
Graber (163) has collected data which indicate that 
an antiserum must contain between 5 and 10 mcg of antibody 
nitrogen to produce visible precipitates when mixed with 
antigen in agar. By contrast, only 003 to .0004 meg-of 
antibody nitrogen is necessary for the fixation of com-
plement. These data suggest a ready explanation why the 
low titered (as measured in the complement fixation test) 
guinea pig sera failed to react in the Ouchterlony agar 
diffusion test. The H. capsulatum strain G17(M) polysac-
charide antigen diluted in saline and stored at 40 C was 
found to be active for at least one month without loss of 
antigenicity in complement fixation tests. The antigenic 
activity of this antigen in complement fixation tests, 
using human sera, has not been studied. 
Skin reactive substances, isolated by chemical 
extraction from cultures of Ho capsulatum, ,Bo dermatitidis, 
and c. immitis have been reported by other investigators (147-154)0 There exists a consensus that an ideal skin 
test antigen, at a critical dilution, should give a maximum 
number of homologous responses and a minimum number of 
heterologous responses; that is, the material should be 
both sensitive and specifico The question of the specifi-
city of fungal skin test antigens is of prime importance, 
because it has been well established that skin test cross 
reactions occur with histoplasmin, blastomycin, and to a 
lesser degree with coccidioidin and haplosporangin (168). 
This lack of specificity is the rationale for testing 
humans suspected of having pulmonary mycoses with the 
three major systemic fungal skin test antigens (histo-
plasmin, blastomycin, and coccidioidin)o 
In this investigation similar skin test reactions 
were observed with polysaccharide substances derived from 
either whole cells or broth o These similar skin test 
reactions obtained with equal amounts of the cell and 
broth polysaccharides suggest that the greater quantity 
of polysaccharides obtained from broth was not due to con-
taminating artifacts but was due to the release of poly-
saccharide substances into the medium during growth. 
In tuberculosis skin tests, the purified protein 
derivative (PPD) has been accepted as a world wide 
standard beeause a known weight of antigen can be in-jected intradermally and the resultant skin reaction is 
reproducible and specific. The polysaccharide antigens 
derived from H. capsulatum and B. dermatitidis also may 
be injected on a weight basis and, in addition, these 
antigens contain no protein, therefore non-specific 
protein hypersensitive reactions can be avoided. 
The biologic assay of histoplasmin, as outlined by 
the National Institutes of Health, requires that the skin 
test antigen, when injected intracutaneously into guinea 
pigs, infected 1 month previously with Ho capsulatum, 
should produce at least a 5 mm area of induration in each 
animal and that the observed mean reaction should be 
equal to the reaction produced by NIH histoplasmin. 
The results of the first and second series of ex-
periments produced variable skin test resultso The results 
shown in Table 13 suggested the possibility that there 
might be a complete strain specificity since the H. cap-
sulatum strain 6651 broth and cellular polysaccharides 
failed to produce skin tests in animals infected with 
Ho capsulatum G170 However, subsequent experiments ruled 
out this possibilityo The results tabulated in Tables 
15 and 16 showed that 100 meg of three strains of lie cap-
sulatum polysaccharides produced skin tests equal to the 
National Institutes of Health histoplasmin. Table 15 
showed that the skin test reactivity of guinea pigs in-
fected intraperitoneally was equal to the skin test act-
ivity of guinea pigs inf.ected intracardially. In 
addition, there appears to be no difference in skin test 
activity when guinea pigs are infected with mycelial 
phase organismso Table 16 also showed that the polysac-
charides extracted from the yeast phase of H. capsulatum 
G17(M) produced skin tests equal to those produced by 
polysaccharides extracted from the mycelial phase of the 
same organism. It is also shown in Table 16 that the 
polysaccharides extracted from the cells of the Ho cap-
sUlatum G17(M) and 6651 produced skin tests slightly 
less than the broth polysaccharides, but the results of 
other comparative studies, in this investigation, have 
shown the cell and broth polysaccharides produce equal 
skin tests e 
In Table 19 are shown the results of skin tests 
comparing two lots of polysaccharides extracted from 
H. capsulatum strains 0651 and G17(M). It is evident 
that the second lot of each polysaccharide produced skin 
tests equal to those produced by the first lot of polysac-
. charideo The trypsin treated polysaccharide, from 2 
strains of He capsulatum, was no different in skin test 
activity for each of the 2 strains of H. capsulatum 
polysaccharide employed. This is further evidence that 
protein does not act as the skin test active substance 
present in these antigenso 
The skin test reactions recorded in Table 20 showed 
that the Bo dermatitidis strain 380 polysaccharide was 
capable of producing positive skin test reactions in 
guinea pigs infected with the same strain of B. derma-
titidise Furthermore:. better reactions were obtained 
with the polysaccharide than were produced by commercially 
available blastomycin. The Bo dermatitidis cell and broth 
polysaccharides appeared.to be equally active. Preference 
must be given to the broth polysaccharide because greater 
quantities can be obtained with the same effort of pre-
paration. The 10 mcg test doses of Ho capsulatum G17(M) 
polysaccharide produced an essentially negative reaction 
in the blastomycotic guinea pigso However, the 100 meg 
H.capsulatum G17(M) polysaccharide showed a degree of 
non-specific reactivityo 
The homologous and heterologous skin test reactions 
of Ho capsulatum strains G17(M) and 6651 polysaccharides, 
and B. dermatitidis strains 380 and 410 polysaccharides 
in 6 guinea pigs infeGted with lio capsulatum and 6 guinea 
pigs infected with B. dermatitidis yeast phase organisms 
are shown in Tables 21 and 22. The B. dermatitidis strains 
380 and 410 polysaccharides, in a concentration of 10 mcg, 
produced specific reactions in the homologously infected 
guinea pigs without non-specific reactions in the Ho eap-
sulatum infected guinea pigso The H. capsulatum polysac-
charides in a concentration of 10 mcg produced acceptable 
skin test reactions in Ho capsulatum infected guinea pigs. 
However, in the Bo dermatitidis infected guinea pigs the 
H. capsulatum polysaccharides skin tests yielded non-
specific cross reactions when 10 mcg doses were used. 
The 2 observed reactions with the 10 mcg of H. capsulatum 
G17(M) polysaccharide were less than the minimum of 5 mm 
of induration and about half the size of the skin test 
reaction in the H. capsulatum infected guinea pigs. 
The previous guinea pig studies revealed that 10 meg 
of Ho capsulatum G17(M) polysaccharide produced a mean 
homologous skin test reaction of 13 mm. This correlates 
well with the mean human skin test reaction of 14 mm 
noted in Table 25 which is concerned with tests on humans. 
A comparison of the human skin test reactions of histo-
plasmin and the H. capsulatum G17(M) polysaccharide tabu-
lated in Table 23 shows that the skin test reactions are 
about equal. It is interesting that the skin test reactions 
of the polysaccharide antigens were almost maximum at 24 
hours and not significantly different from the 48 hour 
reactions. 
All persons exhibiting positive skin tests had spent 
considerable periods of time in the known endemic areas 
of the Mississippi and Ohio River Valleys and western 
portions of the Appalachian Mountains. 
Previous guinea pig skin tests with the B. dermatit-
idis strain 3g0 polysaccharide showed no cross reactions 
in guinea pigs infected with Ho capsulatum, while the com-
mercial blastomycin produced a significant number of cross 
reactions. In humans, the situation seems to have reversed 
itself since the blastc)Inycin showed no cross reactions, 
while a mean of 7 mm of induration of ~on-specific reaction 
was noted with Bo dermatitidis 380 polysaccharide (see 
Table 25). However, the commercial blastomycin was inferior 
to 'Eo dermatitidis polysaccharides in homologous skin tests 
in Bo dermatitidis infected guinea pigso Human blastomycosis 
infections, at the present time, appear to be very infrequent 
in this part of the country, therefore, the chances for a 
comparative study of blastomycin and Bo dermatitidis poly-
saccharides in humans is not feasible. 
The small numbers of persons studied, in this in-
vestigation, are not representative of the population of 
this area, therefore, no conclusions can be drawn concerning 
the incidence of histoplasmin sensitivity for the local 
population. 
86 
The use of a large number of mice in the lie capsul-
~ immunization experiment, comparing whole cell and 
polysaccharide antigens, permitted the concomitant deter-
mination of the LD50 for the immunized and control animals. 
Statistical analyses of these data permits a numerical 
evaluation of the immunization procedureso The calculations 
indicate that these antigens produce a significant degree 
of protection with potency ratios of 7.62 for the whole cell 
antigen and 4.28 for the polysaccharide antigens. In other 
words, 7.62 times the challenge required to kill 50 per 
cent of normal mice is necessary to kill whole cell immu-
nized mice; the corresponding figure in the case of poly-
saccharide is 4.280 Furthermore, no difference was noted 
among animals immunized with 1 or 3 injections of poly-
saccharide. It will be interesting to further explore the 
feasibility of immunizing mice and other animals against 




10 Ho capsulatum strains G17, G17(M) and 6651; and 
~. dermatitidis strains 3eO, 410 and 6052 have each been 
grown in enriched tryptose phosphate broth. This medium 
produced good growth of the yeast phase organisms with 
significant yields of polysaccharides. 
20 Polysaccharides have been extracted from each of 
three strains of H. capsulatum and Bo dermatitidiso The 
polysaccharides were obtained by chemical procedures 
using ethanol and chloroform. This method of polysac-
charide extraction produced up to 3 grams of polysaccharide 
from 6 liters of tht3 fungal broth. Polysaccharides have 
also been extracted from the cellular elements of several 
strains of ~ capsulatum and 1 strain of B.,dermatitidis. 
3. Chemical studies on the hydrolysates of H. ~­
sulatum and Bo dermatitidis polysaccharides polysaccharides 
have shown that they consist mainly of glucose units with 
small amounts of nitrogen. 
40 Investigations of the serologic properties of 
the He capsulatum and B. dermatitidis polysaccharides, 
employing the Oudin and Ouchterlony technics have shown 
specific lines of precipitates opposite the homologous 
antibody, without evidence of cross reactions with other 
fungal antisera. The H. capsulatum G17(M) polysaccharide· 
has been used as a satisfactory complement fixing antigen, 
when hyperimmune rabbit or guinea pig sera are used. 
5. A major variable in skin testing H. capsulatum 
and ~o dermatitidis infected guinea pigs was shown to be 
the degree of skin hypersensitivity of the infected 
animals 0 A comparison of the skin test activities of H. 
capsulatum polysaccharide and NIH Lot #2 histoplasmin showed 
that these polysaccharides produce a degree of induration 
equal to the NIH standard histoplasmino Unfortunately, 
similar:comparative studies of B. dermatitidis polysac-
charides could not be conducted because blastomycin has 
not been standardized by the National Institutes of Health. 
However, the Be dermatitidis polysaccharides produced more 
consistant skin test reactions than did a commercial 
blastomycino Comparative skin test investigations of poly-
saccharides derived from the broth and cellular elements 
of these fungi have .shown equal skin test activity. However, 
preference for the broth polysaccharides was based on the 
greater quantity of extractable polysaccharide present in 
88 
the broth. Polysaccharide extracted from the mycelial 
phase of H. capsula tum has shown skin test reactions 
comparable to the polysaccharide extracted from the yeast 
phase broth of the same strain of fungi. Preference, once 
again, was shown for the yeast phase organisms because 
the hazards of pulmonary infections could be avoided. 
Quantitative studies of the homologous and hetero-
logous skin test reactions of lie capsulatum and B. derma-
titidis polysaccharides have shown that a specific homo-
logous skin test reaction depends on the amount of poly-
saccharide injected, and that by employing optimum con-
centrations it was possible to produce specific skin test 
reactions. 
6. Human skin tests have been conducted using H. 
cagsulatum G17(M) polysaccharide and B. dermatitidis strain 
38 polysaccharide. One hundred thirty four volunteers 
were injected intradermally with H. capsulatum and 
B. dermatitidis polysaccharides and the skin test reactions 
compared with the skin test reactions produced by the 
intradermal injection of histoplasmin and blastomycin. 
Twenty positive skin tests were observed, and a comparison 
of the skin test reactions elicited by the polysaccharide 
and the histoplasmin were made. This study has shown that 
10 mcg of H. capsulatum G17 polysaccharide produced skin 
tests equal in sensitivity and specificity to those observed 
with histoplasmin. No specific B. dermatitidis strain 380 
polysaccharide skin tests were observed; however, 10 mcg of 
the B. dermatitidis polysaccharide produced minimal non-
specific skin test reactions in a few of the persons ex-
hibiting positive H. capsulatum skin tests.' 
7. The H. capsulatum strain G17(M) polysaccharide 
was capable of producing active resistance in mice. 
However, mice immunized with a whole cell antigen showed 
greater resistance when the He capsulatum polysaccharide 
immunized, whole cell immunized and non-immunized control 
groups of mice were challenged by the intravenous injection 
of known numbers of viable Ho capsulatum G17(M) yeast phase 
organisms. 
REFERENCES 
1. Darling, S. T. 1906 A protozoan infection producing 
pseudotubercles in the lungs and focal necroses 
in spleen, liver, and lymph nodes. J.A.M.A. 
~:1283. 
2. Darling, S. T. 1909 The morphology of the parasite 
H. capsulatum and lesions of histoplasmosis, a 
fatal disease of tropical America. J. Exper. Med. 
11:515. 
3. DeMonbreun, W. A. 1934 The cultivation and cultural 
characteristics of Darling's H. capsulatum. 
Am. J. Trop_ Med. ~:93. 
4. Smith, C. E., Whiting, E. D., Barker, E. E., Rosenberg, 
H. G., Beard, R. R., and Saito, M. T. 1948 The 
use of coccidioidin. Am. Rev. Tuberc. 21:330. 
5. Christie, A. and Peterson, J. C. 1945 Pulmonary 
calcifications in negative reactors to tuberculin. 
Am. J. Pub. Health 1i:1131. 
6. Palmer, C. E. 1945 Nontuberculous pulmonary calcifi-
cations in negative reactors to tuberculin. Pub. 
Health Rep. 22:513. 
7. Furcolow, M. L., High, R. H., Allen, M. F. 1946 Some 
epidemiological aspects of sensitivity to histoplasmin 
and tuberculin. Pub. Health Rep. 61:1132. 
8. Christie, A.., and Peterson, J. C. 1946 Histoplasmin 
sensitivity. J. Pediat. l2:417. 
9. Christie, A., and Peterson, J. C. 1946 Pulmonary.cal-
cification and sensitivity to histoplasmin tuberculin 
and haplosporangin_ J.A.M.A. 131:658. 
10. Sontag, L. W. and Allen, J. E. 1947 Lung calcifi-
cations and histoplasmin-tuberculin skin sensitivity. 
J. Pediat. 1Q:657. 
11. High, R. H., Zwerling, H. B. and Furcolow, M. L. 1947 
Disseminated pulmonary calcification; report of 
113 cases. Pub. Health Rep_ 62:20. 
12. 
90 
Peterson, C. J. and Christie, A. 1948 




13. Bunnell, I. L. and Furculow, M. L. 1948 Variations 
in histoplasmin sensitivity in certain cities in 
eastern Kansas. Pub. Health Rep. 21:1298. 
14. Absher, W. K., and Cline, F. Jr. 1949 A correlated 
study of tuberculin, histoplasmin) and coccidioidin 
sensitivities with pulmonary calcifications in the 
Rocky Mountain area. Am. Rev. Tuberc. 22:643. 
15. Zahn, D. W. 1949 Pulmonary infiltration·associated 
with sensitivity to histoplasmin: report of case. 
Am. Rev. Tub ere • 22:636. 
16. Sutliff, W. D., Hughes, F., Ulrich, E., and 'Btir~ett,e, L. L. 
Active chronic pulmonary histoplasmosis. A.M.A. 
Arch. Int. Med. ~:571. 
17. Furcolow, M. L., Schwarz, J., Hewell, B. A. and Grayston, 
J. T. 1953 Incidence of tuberculin, histoplasmin, 
and blastomycin reactors among a group of school 
children. Am. J. Pub. Health ~:1523. 
18. Tucker, H. A. 1952 Histoplasmosis on the Isthmus of 
Panama. Am. J. Trop. Med. 1:462. 
19. Inglis, J. A. and Powell, R. E. 1953 Histoplasmosis: 
A review with report of a fatal Australian case. 
M.J. Australia 1:138. 
20. Edwards, P. Q. and Kier, J. H. 1956 World wide 
geographic distribution of histoplasmosis and 
histoplasmin sensitivity. Am. Rev. Tuberc. 2:235. 
21. Poles, F. C. and Lavertine, J. D. o. 1954 Acute 
disseminated histoplasmosis with a report of a 
case occurring in England. Thorax 2:233. 
22. Schwartz, B. and Spitz, L. J. 1952 Histoplasmosis 
in epidemic form: a follow up study. A.M.A. Arch. 
Int. Med. ~:541. 
23. 1oos1i, C. G., Procknow, J. J., Tanzi, F., Grayston, 
J. T. and Combs, L. W. 1951 Pulmonary histo-













Emmons, Ce W. 1949 Isolation of Histoplasma cap-
sulatum from soil. Pubo Health Rep. 64:892. 
Grayston, J. Te, Loosli, Co Go and Alexander, Ee R. 
1951 The isolation of Histoplasma capsulatum 
from soils in unused siloo Science 114:323. 
Furcolow, Me L. and Larch, Ho Wo 1952 Direct isola-
tion of Histoplasma capsulatum from soil: 
probable etiological relationship to Camp Gruber 
pneumonitis. Froco Soco Expero Biolo & Med. 80:246. 
Zeidberg, L. D., Ajello, Lo , Dillon, A. and Runyon, 
L. C. 1952 Isolation of Histoplasma capsulatum 
from soil. Amo J. Pubo Health ~:930. 
Gordon, M. Ao and Cup, H. Bo Jro 1953 Detection of 
Histoplasma capsulatum and other fungus spores 
in the environment by means of the membrane filter. 
Mycologia ~:24lo 
Ajello, L" and Runyon, L. Co 1953 Infection of mice 
with single spores of Histoplasma capsulatum. 
J. Bact. 66:340 
Ibach, M. J. t Larsh. H. W. and Fursolow. Me L. 1954 
Epidemic histoplasmosis and airborne Histoplasma 
capsulatum. Proe. Soc. Exper. BioI. &. Med. 1!2,:7.2. 
,.. <!, 
Zeidberg, L. De, Dillon, A. and Gass, R. S. 1954 
Environmental factors influencing the occurrence 
of Histoplasma capsulatum and Microsporum gypseum 
in soil. 
Kier, J e H., Campbell, Co, Ajello, L. and Wheelam, D. S. 
1954 Acute bronchopneumonic following exposure to 
infected garden soil. J.A.MeA. 122:1230. 
Zeidberg, L. D. 1954 A theory to explain the geo-
graphic variation in the prevalence of histoplasmin 
sensitivity. Am. J. Tropo Med. 1:1057. . 
Furcolow, M. L. and Ruhe, J. So 1949 Histoplasmin 
sensitivity among cattle. Am. Jo Pub. Health 12:719. 
Randall, C. C., Orr, M. Fe, Schell, Fe G. 1951 
Detection by tissue culture of an organism resembling 
Histoplasma capsulatum in an apparently healthy 
horse. Proc. Soc. Expero BioI. & Med. ~:447. 
92 
36. Cole, Co R., Farrell, Ro L., Chamberlain, D. M., 
Prior, J. A. and Saslaw, S. 1953 Histoplasmosis 
in animals. Am. Vet. M. A. 122:471. 
37. Rowley, Do A., Haberman, R. T. and Emmons, C. w. 
1954 Histoplasmosis pathologic studies of fifty 
cats and fifty dogs from Soudoun County, Virginia. 
J. Infect. Dis. 22:98. 
38. Emmons, C. W. and Rowley, D. A. 1955 Isolation of 
Histoplasma capsulatum from fresh and deep-frozen 
peribronchial lymph nodes of dogs by mouse inocu-
lation. J. Lab.& Clin. Med. ~:303. 
39. Emmons, C. W., Rowley, D. A., Olson, B. J., Mattern, 
C. Fo T., Bell, J. A., Powell, E. and Marcey, E. A. 
1955 Histoplasmosis: proved occurrence of inap-
parent infection in dogs, cats and other animals. 
Am. J. Hyg. 61:40 0 
40." Furcolow, M. L., Menges, Ro Wo and Larsh, H. W. 1955 
An epidemic of histoplasmosis involving man and 
animals. Anno Int. Med. ~:1730 
41. Middleton, Jo G., McVickar, D. L. and Peterson, J. C. 
1950 Experimental histoplasmosis in white rat. 
Proc. SOCo Exper. BioI. & Med. li:164. 
42. Kotcher, E., Robinson, J. W. and Miller, M. P. 1951 
The isolation of Histoplasma capsulatum from 
tissues of experimentally infected mice. J. Bact. 
62: 6130 
43. Farrell, R. Lo, Cole, Co R., Prior, J. A. and Saslaw, S. 
1953 Experimental histoplasmosis. I. Methods for 
production of histoplasmosis in dogs. Proc. Soc. 
Expero BioI. & Med. ~:5l. 
44. Salvin, S. B. 1954 Cultural and serologic studies 
on nonfatal histoplasmosis in mice, hamsters, and 
guinea pigs. J. Infect. Dis. ~:22. 
45. Howell, A. Jr. and Kipkie, G. F. 1951 A comparison of 
the susceptibility by intracerebral inoculation of 
six strains of mice with DBA line 1 mice. Am. J. 
Trop. Med. 11:33. 
46. Howell, A. Jr., Kipkie, G. F. and Bruyere, P. To 1950 
Studies on experimental histoplasmosis. Pub. Health 
Rep. 2..2:7220 
93 
47. Marcus, S. and Rambo, F. R. 1952 Reproducible 
systemic mycotic infections in mice. Bact. Froc. 
M34. 
48. Rowley, Do A. and Huber, M. 1955 Pathogenesis of 
experimental histoplasmosiso J o Infect. Dis • 
.2.§.:174. 
49. Campbell, C. C. and Saslaw, S. 1950 Use of mucin 
in experimental infections of mice with Histo-
plasma capsulatum infections. Proc. Soc. Exper. 
BioI. & Med. 11:469. 
50. Howell, A. Jr. and Kipkie, G. F. 1950 Experimental 
histoplasmosis. Susceptibility of male DBA line 1 
mice by various routes of injection. Froco Soc. 
Expero BioI. & Med. 12:121. 
51. Pinkerton, He and Iverson, L. 1952 Histoplasmosis. 
Three fatal cases with disseminated sarcoid-like 
lesions. A.M.A. Arch. Int. Med. 2Q:456. 
52. Straub, Mo and Schwarz, J. 1955 The healed primary 
complex in histoplasmosis. Am. J. Path. ~:727. 
53. Furcolow, Me Lo and Brasher, C. A. 1956 Progressive 
histoplasmosis as a problem in tuberculosis 
sanatoriums. Am. Revo Tuberc. 11:609. 
54. Pucket, To Fe 1953 Pulmonary histoplasmosis. Am. Rev. 
Tuberc • .21:4530 
55. Silverman, F. No, Schwarz, Jo, Lahey, Me Eo and Carson, 
R. P. 1955 Histoplasmosis. Am. J. Med. 12:410. 
56. Schwartz, S. O. and Barsky, S. 1952 Report of 193 
marrow biopsy specimens cultured for Histoplasma 
capsulatumo Blood 1:545. 
57. McVickar, D. L. 1951 Factors important for the 
growth of Histoplasma capsulatum in the yeast cell 
phase on peptone media. Jo.Bact. 62:137. 
58. Marcus, S., Nielson, B. D. and Rambo, F. R. 1956 
Isolation of systemic mycotic pathogens: qual-
itative and quan~itative aspects. J. Bact. 11:473. 
59. Georg, L. Ke, Aje11o, L. and Papageorge, C. 1954 
Use of cycloheximide in the selective isolation 
of fungi pathogenic to man. J. Lab. & Clin. Med. 
lrl±:422. 
94 
60. Zarafonetis, C& Jo Do 1952 Dubos medium with albumin 
for yeast phase growth of Hi.stoplasma capsulatum. 
Am. J. Clino Path. ~:9l1o 
61. Pine, L. 1954 
capsulatum. 
Studies on the growth of Histoplasma 
Je Bact. 68:671. 
62. Rowley, ID. Ao and Pine, 1. 1955, Some nutritional 
factors influencing growth of yeast cells of 
Histoplasma capsulatumoJo Bact. 22:695. 
63. White, Fo Co 1955 Chronic pulmonary disease in 
histoplasmin reactors. Am. Rev. Tuberc. zg:274. 
64. Zarafonetis, Co J. D. and Lindberg, R. B. 1941 
Histoplasmosis of Darling: Observations on the 
antigenic properties of the causative agent. 
Univ. Hosp. Bulle Ann Arbor, Michigan 1:47. 
'65. Schubert, J e H., Ajello, 1 0 , Cooper, J. S. and Runyan, 
1. C. 1955 Evaluation of histoplasmin and yeast 
phase antigens derived from a single strain of 
Histoplasma capsulatum in the complement fixation. 
test. J. Bact~ £2:558. 
66. Schubert, Jo, Ajello, 1., Stanford, S. and Grant, V. Q. 
1953 Variations in complement fixation antigen 
production by different strains of Histoplasma 
capsulatum grown on two media. J. Lab. & Clin. 
Med. ll:9l. 
67. Dyson, J. E. and Evans, E. E. 1954 Skin test antigens 
from yeast phaS:e cultures of Blastomyces dermati-
tidis and Histoplasma capsulatum. Univ. Michigan 
Med. Bull. ~:53. 
68. Hill, G. A., Marcus, So and Baker, Ko R. 1953 
Serologic characteristics of four systemically 
pathogenic fungi. Bact. Proc. G380 
69. Norden, A. 1949 Agglutination of sheep's erythro-
cytes sensitized with histoplasmin. Proc. Soc. 
Exper. BioI. & Med. 12:218. 
70. Salvin, S. B. and Furcolow, M. Lo 1954 Precipitins 
in human histoplasmosis. J. 1ab. & Clin. Med. 
ll: 259. 
71. Oudin, J. 1952 Spec precipitations in gels and 
its application to immunochemical analysis. 
Methods of Medical Research. 2:335. 
95 
72. Ouchterlony, 0 0 1949 Antigen-antibody reactions in 
gelso Acta path. et microbiol. Scandinav. 26:507. 
73. Wilson, H. M. and Duryea, A. W. 1952 Pulmonary 
histoplasmosis: Report of a case of long con-
sidered tuberculosis improved by acti-dione. 
Dis. Chest ~:346. 
74. Emmons, Co W. and Haberman, Re T. 1953 Ascosin in 
the treatment of experimental histoplasmosis in 
mice. Antibiotics & Chemothero 1:1204. 
75. Christie, A., Middleton, J o G., Peterson, J. C. and 
McVickar, Do 1. 1951 Treatment of disseminated 
histoplasmosis with ethyl vanillate. Pediatrics 
1:7. 
76. Hansen, A. E. and Beene, Mo 1. 1951 Sensitivity 
studies in vitro with Histoplasma capsulatum to 
various potential therapeutic agents. Froc. Soc. 
Exper. BioI. & Med. 11:365. 
77. Campbell, C. Co and Saslaw, S. 1951 Atabrine therapy 
of histoplasma infections in mice. Pub. Health 
Rep. 66:570. 
78. 1amb, J. H. 1954 Combined therapy in histoplasmosis 
and coccidioidiomycosiso A.M.A. Arch. Dermat. & 
Syph. 1Q:695o 
79. Curtis, A. C., Bocobo, Fe, Hannell, E. R. and Block, 
We D. 1954 Further studies on antifungal activity 
of some cinnamic acid deratives and nitrostyrenes. 
A.M.A. Arch. Dermato & Syph. 1Q:786. 
80. Baum, G. 1., Schwarz, J o and Wang, C. J. K. 1958 
Treatment of experimental histoplasmosis with 
amphoterisin B. A.M.A. Arch. Int. Med. 101:84. 
81. Gilchrist, T. C. 1894 A case of Blastomvces derma-
titidis in man. Johns Hopkins Hosp. Rep. 1:271. 
82. Benham, R. W. 1950 Blastomyces: review of literature. 
Ann. New York Acad. Sc. 2Q:1299. 
83. Gilchrist, T. C. and Stokes, W. Ro 1896 The presence 
of an oidium in the tissues of a case of pseudo-
lupus vulgaris. Johns Hopkins H?sp. Bull. 1:129. 
84. Gilchrist, T. C. 1896 Cited the work of Corelli and 
Frisco. Johns Hopkins Hosp. Bull. 1:129. 
96 
850 Gilchrist, To Co 1896 Cited the work of Porrcali. 
Johns Hopkins Hosp. Bullo 1:1290 
86. Gilchrist, To Co 1896 Cited the work of Curtis. 
Johns Hopkins Hosp. Bullo 1:129. 
87. Martin, Do So and Smith, Do To 1939 Blastomycosis: 
10 Review of literatureo Am. Revo Tuberc. 12:275. 
880 Shepherd, Fo J o and Rhea, Lo 10 1911 A fatal case 
of blastomycosiso J o Cutano Diso ~:5880 
89. Dowling, Go Bo and Elworthy, Ro R. 1925 A case of 
blastomycetic dermatitidis o Froco Roy. Soco Med. 
12:40 
90. Schwarz, J o and Goldman, Lo 1955 Epidemiologic 
study of North American blastomycosis. A.M.A. 
Archo Dermato & Sypho 11:84. 
91. Ramsey, F. Ko and Carter, G. Ro 1952 Canine blasto-
mycosis in United States. J o Amo Vet. M.A. 20:93. 
92. Menges, R. We, McClellan, J. T. and Ausherman, R. J. 
1954 Canine histoplasmosis and blastomycosis cases 
in Lexington, Kentuckyo J o Am. Vet. M.A. 124:202. 
93. Schwarz, Jo and Baum, G. Lo 1951 Blastomycosis. 
Am. J o Clino Patho 21:9990 
94. Schwarz, J o and Baum, G. Lo 1953 North American 
blastomycosis (geographic distribution, pathology 
and pathogenesis)o Documo medo geogo et troPe 2:29. 
95. Harris, J o So, Smith, J o Go, Humbart, We Co, Conant, 
No Fo and Smith, Do To 1957 North American 
blastomycosis in an epidemic area. Pub. Health. 
Repo 11:95. 
96. Wilson, Wo J o, Cowley, Eo Po, Weidman, Eo Do and 
Gilmer, Wo x~ 1955 Primary cutaneous North 
American blastomycosis. A.MoA. Arch. Dermat. & 
Sypho 11:39. 
97 •. Curtis, Ao Co and Bocobo, Fo Co 1957 North American 
blastomycosiso J o Chron. Dis. i:404. 
980 Montgomery, F. Ho 1902 A brief summary of the 
clinjcal, pathologic and bacteriologic features 
of cutaneous blastomycosis. JoAoM.Ao ~:1386o 
97 
99. DtAunoy, Ro and Beven, Je Le 1930 Systemic blasto-
mycosiso J o Labo & Clino Med. 16:124. 
100. Martin, Do So and Smith, Do To 1939 Blastomycosis 
110 Report of 13 caseso AmoRevo Tuberco 12:488. 
101. Freidman, Lo So and Signorelli, Jo J. 1946 Blasto-
mycosis: A brief review of literature and a 
report of a case involving the meninges. Ann. 
Into Med. ~:385o 
102. Stober, Ao M. 1914 Systemic blastomycosis: A 
report of its pathological and clinical features. 
A.M.Ao Arch. Int. Medo 11:5090 
103. Gair, C. Co 1925 Systemic blastomycosis. Surge 
Gyneco & Obst. ~:490o 
104. Feld, Do Do and Codden, Ao V. 1949 Systemic blasto-
mycosis. Diso Chest 16:4720 
105. Lowery, Co Co, Kraeft, No Ho and Hughes, F. A. Jr. 
1951 Blastomycosis of the lung. Am. J. Surge 
81:6760 
106. Tuttle, J. Go, Lichtwardt, Ho Eo and Altshuler, Co H. 
1953 Systemic North American Blastomycosis. 
Report of a case with small forms of blastomyces. 
Am. J. Clin. Path. ~:890. 
1070 Steen, Lo Ho, Foxworth, D. T. and Baker, L. A. 
1954 Acute blastomycotic pneumonia, a report of 
a fatal case of short duration diagnosed by needle 
biopsy of lung. AoM.A. Archo Int. Med. 21:464. 
108. Cherinis, E. 10 and Waisbren, Bo Ao 1956 North 
American blastomycosis: A clinical study of 40 
cases. Ann. Int. Med. ~:1050 
109. Brown, R. Ko and Cummins, Wo Te 1915 A differential 
study of coccidioidal granuloma and blastomycosis. 
10 Pathology and bacteriologye 110 Report of 
two additional cases of coccidioidal disease. 
A.MeA. Arch. Into Medo 12:6050 
110. Michelson, I. Do 1928 Blastomycosis. A pathologic 
and bacteriologic study. JoA.MoAo 21:18710 
Ill. Kelley, Wo A. 1939 A study of the cell and colony 
variations of Blastomyces dermatitidis. J o Infect. 
Dis 0 .9li,: 293 0 
98 
112. Littman, Mo Lo, Wicker, Eo Ho and Warren, Ho So 
1948 Systemic North American blastomycosis: 
Report of a case with cultural studies of the 
etiologic agent and observations on the effect 
of streptomycin and penicillin in vitroo Am. 
J. Path. ~:339o 
113. Weed, Lo Ao 1955 North American blastomycosis. 
Amo Jo Clino Path. ~:37. 
114. DeMonbreun, Wo Ao 1935 Experimental chronic 
cutaneous blastomycosis in monkeys. A study of 
the etiologic agent. AoM.Ao Arch. Dermato & Syph. 
ll: 8310 
115. Baker, Ro Do 1939 The effect of mouse passage on 
cultural characteristics and virulence for mice 
of organisms causing blastomycosiso Amo J. 
Tropo Medo 12:5470 
116. Davis, Bo Fo 1911 The immunologic reactions of 
oidiomycosis (blastomycosis). J. Infecto Diso 
8:1900 
117. Martin, D. So 1941 The practical application of 
some immunologic principles to the diagnosis 
and treatment of certain fungus infections. 
J. Invest. Dermat. ~:47lo 
118. Martin, D. S. 1957 Evaluation of skin tests and 
serologic methods in fungus infectionso 
J o Chrono Diso 2:5800 
119. Perry, Ho 0 0 , Weed, Lo Ao and Kierland, Ro R. 1954 
South American blastomycosiso Report of case 
and review of laboratory features. AoMoA. Archo 
Dermato & Sypho 12:4770 
120. Martin, Do So 1935 Complement fixation in blasto-
mycosiso J. Infect. Diso 21:2910 
121. Smith, Do To 
mycosiso 
1l:463. 
1949 Immunologic types of blasto-
A report of 40 caseso Ann. Into Med. 
1220 Martin, Do So 1953 Serologic studies on Nprth 
American blastomycosis. J o Immuno10 ]1:1920 
99 
123. Schoenbach, Eo Bo, Miller, J 0 Mo, Ginsberg, M. and Long, 
Po Ho1951 Systemic blastomycosis treated with 
stilbamidine. JoA.MoAo 146:13170 
124. Heilman, Fa Ro 1952 Effect of stilbamidine on 
blastomycosis in miceo Proco Staff Meet. Mayo 
Clino n,:455. 
125. Schoenbach, Eo B., Miller, J'O M. and Long, Po H. 
1952 The treatment of systemic blastomycosis 
with stilbamidine. Anno Into Med. 11:31. 
126. Praiser,' Ho, Levy, Eo Do and Rawson, A. J. 1953 
Treatment of blastomycosis with stilbamidine. 
J.AoM.A. 152:129. 
127. Snapper, I. and McVay, Lo Vo Jro 1953 The treatment 
of North American blastomycosis with 2-hydroxy 
stilbamidineo Amo J o Med. 12:603. 
128. Schwarz, J o and Adriano, S. 1953 Failure of 
stilbamidine to arrest experimental blastomycosis 
in miceo J o Invest. Dermat. 20:3290 
129. Christison, 10 Bo and Conant, N. F. 1953 Antifungal 
activity of some aromatic diamidines. J. Lab. & 
Clin. Med. ~:63$. 
130. Slaughter, J. Co 1954 Stilbamidine in treatment 
of widely disseminated blastomycosis (with two 
year follow up). AoM.A. Arch. Dermat. & Sypho 
1Q:663 0 
131. Weinberg, B. J., Lawrence, Co H. and Buchnolz, A. 
1954 Systemic blastomycosis treated with 
hydroxy stilbamidineo A.M.A. Arch. Int. Med • 
.2.li.: 493 0 
1320 Stutliff, W. Do, Kyle, Wo J. and Hobson, J. L. 1954 
North American blastomycosis, clinical form of 
the disease and treatment with stilbamidine and 
2-hydroxy stilbamidine. Anno Into Med. ~:89. 
133. Takaro, J., Hopkins, J o Eo To and Murphy, J. Do 1955 
Treatment of pulmonary blastomycosis. Dis. Chest 
~:203. 
'134. Harrell, Eo Ro, Bocobo, Fo Co and Curtis, Ao C. 1955 
A study of North American blastomycosis and its 
treatment with stilbamidine and 2-hydroxy 














Burger, Mo 1950 Bacterial polysaccharides 
Charles Co Thomas, Publisher. 
Heidelberger, M. and Menzel, Ao 1932 Specific and 
non-specific polysaccharides of the human type 
tubercle bacillus. Proc. Soc. Exper. BioI. & Med. 
~:63l. 
Heidelberger, Mo and Karjala, S. 1939 Specific and 
non-specific cell polysaccharides of bovine 
strain of tubercle bacillus. J. BioI. Chern. 
127:221. 
Karjala, S. and Heidelberger, Mo 1941 Specific and 
non-specific polysaccharides of an avian strain 
of tubercle bacillus. J. BioI. Chern. 111:189. 
Heidelberger, M., Kendall, F. E. and Scherp, H. W. 
1936 The specific polysaccharides of types I, 
II, and III pneumococcus. J. Exper. Med. ~:559. 
Heidelberger, Mo, Macleod, Co M., Markowitz, H. and 
Roe, A. S. 1950 Improved methods for the 
preparation of the specific polysaccharides of 
pneumococcus. J. Exper. Med. 21:341. 
Raistrick, H. and Topley, W. W. C. 1934 Immunizing 
fraction isolated from Bact. aertrycke. Brit. 
J. Exper. Path. 12:113. 
Palmer, J. W. and Gerlough, T. D. 1940 A simple 
method for preparing antigenic substances from 
the typhoid bacillus. Science ~:155. 
Nichols, P. S. 1946 On the antigenic structure of 
Bacterium tularense. PhoD. Thesis, University 
of Cincinnatio 
Alexander, M. Mo , Wright, G. Co and Baldwin, A. C. 
1950 Observation of polysaccharide treated 
erythrocytes agglutinated by tularemia antisera. 
J. Exper. Med. 2l:56l. 
Oeding, P. 1954 Immunochemical studies of staphylo-
coccal polysaccharides. Acta path. et micro. 
bioI. scandinav. 12:484. 
Vogel, R. 1954 Polysaccharides of Candida albicans. 












Hirsch, Eo Fo and Benson, Ho 1927 Specific skin 
reactions with culture filtrates of Coccidioides 
immitis. J. Infeco Diso ~:6290 
Hirsch, E. F. and D'Andrea, Do 1926 The specific 
substance of Coccidioides immitiso J. Infec. Dis. 
~:634. 
Hirsch, Eo Fo and D'Andrea, Do 1927 Sensitization 
of guinea pigs with broth culture filtrates and 
killed mycelium of Coccidioides immitis. J. Infect. 
Dis 0 1:&:0380 
Van Fernis, Fo Ao, Benson, M. and Holinger, Po H. 
1941 Specific cutaneous reactions in histo-
plasmosis. J.AoMoA. 117:436. 
Hassid, W. Zo, Baker, Eo Eo and McCready, R. M. 
1943 An immunologically active polysaccharide 
produced by Coccidioides immitis. J. BioI. Chem. 
1.21t:305. 
Peck, Ro, Martin, Do So and Hauser, C. 1940 Poly-
saccharides of Blastomyces dermatitidis. J. Immunol. 
J o Immunol. ~:449o 
Scheff, G. J. 1945 Biochemical and immunological 
properties of Histoplasma capsulatum no. 650. 
Yale J. Bioo & Medo ~:4l. 
Cross, Fo and Howell, A. Jro 1948 Preliminary 
report on the isolation of the immunologically 
active polysaccharide from histoplasmin. Pub. 
Health Rep. ~:179o 
Hill, Go Ao 1954 The serological characteristics 
of five systemically pathogenic fungi. Master's 
Thesis, University of Utah o 
Wilcoxon, Fo and Litchfield, J o T. 1954 A simplified 
method of evaluating dose effect experiments. 
J. Pharm. and Expero Therap. 22:99. 
Sevag, Mo, Lackman, Do Bo and Smolens, Jo 1938 
The isolation of the components of streptococcal 
nucleoproteins in a serologically active form. 











Miya~ F. 1955 The biosynthesis of ribose occurring 
l.n a bacterial polysaccharide. Master's Thesis. 
Brigham Young University. 
Stattler, L. and Zerbon, Fe W. 1952 A new spray 
reagent for paper chromatography of reducing 
sugars. Anals. of Chem. ~:1862. 
Dische, Z. and Shettles, L. B. 1948 A specific 
color reaction for methyl pentoses and a spectro-
photometric micro method for their determination. 
J. Bio. Chern. 112:595. 
Fester, H. J. 1950 Manual for standardized pro-
cedures for spectrophotometric chemistry. 
Standard Scientific Supply Corp., New York City, 
New York. 
Halbert, S. P., Swick, L. and Sonn, C. 1955 The use 
of precipitin analysis in agar for the study of 
human streptococcal infections. II. Ouchterlony 
and Oakley technics. J. Exper. Med. 101~557. 
Grabar, P. in Boyd, W. C. 1956 Fundamentals of 
Immunology. 3rd Edition p. 94 Inter Science-
Publishers Ltd., London. 
Smith, C. E., Saito, M. T. and Simon, S. A. 1956 
The pattern of 39,500 serologic tests in coccidio-
idomycosis. J.A.M.A. 1:546. 
Serologic tests for syphilis, 1955 manual. Public 
Health Service Publication #411 United States 
Government Printing Office, Washington, D. C. 
Middlebrook, G. and Dubos, R. J. 1948 Specific 
serum agglutination of erythrocytes sensitized 
with extracts of tubercle bacilli. J. Exper. Med. 
88:521. 
Allen, W. M. 1950 A simple method of analyzing 
complicated absorption curves of use in the 
colorimetric determination o·f urinary steroids. 
J. Clin. Endocrinol. 12:71. 
Smith, C. E. 1952 Analogy of coccidioidin and 
histoplasmin sensitivity. Froc. Conf. on Histo-
plasmosis Public Health Monograph #39, p. 173. 
THE CHEMICAL, SEROLOGIC AND SKIN TEST ACTIVITIES 
OF POLYSACCHARIDES EXTRACTED FROM HISTOPLASMA 
CAPSULA TUM AND BLASTOMYCES DERMATITIDIS 
by 
Ralph A. Knight 
An abstract of a thesis submitted to 
the faculty of the University of Utah 
in partial fulfillment of the require-
ments for the degree of 
Doctor of Philosophy 
Department of Bacteriology 
Approved by the faculty committee in 
July, 1958 
Dr. Stanley Marcus, Chairman, Thesis Committee 
University of Utah 
1958 
I 
Polysaccharides were extracted by the chemical method 
of Heidelberger, from each of three strains of Histoplasma 
capsulatum and Blastomyces dermatitidis o Significantly 
greater yeilds of polysaccharides were extracted from the 
culture broth filtrate than were extracted from the yeast 
phase cells. 
Studies of the constituents of these polysaccharides 
by paper chromatography and cystiene-sulfuric acid tests 
for pentose and hexose, micro-Kjedhahl nitrogen and other 
qualitative and quantitative chemical tests suggest that 
the H. capsulatum and B. dermatitidis polysaccharides con-
sisted of glucose units with an occassional glucoseamine 
moiety. 
The capacity of the H. capsulatum and B. dermatitidis 
polysaccharides to produce visible antigen-antibody precip-
itates with homologous and heterologous antisera were in-
vestigated by the Oudin and Ouchterlony agar precipitation 
methods. These studies showed that the H. capsulatum and 
the B. dermatitidis polysaccharides reacted only with their 
respective homologous antibody and that each produced a 
single band of precipitate. These data indicated that each 
antigen had a specific in vitro antigenic action, with one 
antigenically active component. 
Complement fixation and hemagglutination tests were 
employed using the He capsulatum polysaccharide antigen. 
2 
This study showed that the polysaccharide antigen could be 
used as a complement fixation antigen when hyperimmune 
guinea pig or rabbit sera were used as antibody. Hemag-
glutination test results were not reproducible. 
The H. capsulatum and Bo dermatitidis polysaccharides 
were used as skin test antigens. The intradermal injection 
of microgram amounts of these polysaccharides into guinea 
pigs infected with either H. capsulatum or B. dermatitidis 
produced skin test reactions equal to those given by the 
standard histoplasmin or blastomycin. A study of the skin 
test cross reaction of the H. capsulatum polysaccharides and 
B. dermatitidis polysaccharides in the guinea pigs infected 
with B. dermatitidis or H. capsulatum revealed specific skin 
test reactions without significant cross reactivity. lie 
capsulatum and B. dermatitidis polysaccharide antigens were 
injected intradermally into 136 human volunteers. Twenty 
positive reactions were observed and a comparison of the 
extent of induration produced by histoplasmin and 10 mcg 
of H. capsulatum showed that the H. capsulatum polysacchar-
ide produced skin test reactions equal to those observed 
with histoplasmin. Specific Bo dermatitidis skin test 
reactions were not observed; however, minor skin test re-
actions were observed following injection of the B. derma-
titidis polysaccharides in a few persons who showed strong 
3 
reactions with Ho capsulatum skin test materials. These 
studies suggest that fungal polysaccharides, isolated by 
relatively simple chemical methods, may be more suitable 
for use as skin test antigens than the currently available 
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RESEARCH PROPOSALS 
1. Definitive studies of Ho capsulatum and B. derma-
titidis polysaccharides are desirable. For example: counter 
current distribution procedure could be employed to separate 
H. capsulatum and Be dermatitidis polysaccharides.' This 
project could be conducted in association with the biochem-
istry research unit of the Veterans Administration Hospital, 
Salt Lake City, Uti.aho The investigation would be designed 
to determine if the unhydrolysed polysaccharides can be 
separated or purified by this method. If these polysac-
charides could be separated by counter current distribution, 
the antigenic activity of the various fractions could then 
be tested by skin test and the Ouchterlony technics. 
2. Further serologic studies of fungal polysaccharides 
are desirable. Further effort woUld be made to study hemag-
glutination reactions of these polysaccharides. The reasons 
for the failure of these polysaccharide antigens to be 
adsorbed by sheep red blood cells, or rather the failure 
to obtain hemagglutination of these sensitized red blood 
cells should be further investigated. Perhaps the treatment 
of the cells with dilute tannic acid may produce a red blood 
cell that will adsorb antigen and then react with antibody. 
3. Literature has been cited in the thesis to show 
that fungal polysaccharide antigens can not be used as 
complement fixation antigens when human sera are tested. 
2 
There is no theoretical basis to support such findings. 
There is indicated a comparative study of whole cell, cell 
free extract antigens and the corresponding H. capsulatum 
and B. dermatitidis polysaccharides used with human sera 
containing li. capsulatum or B. dermatitidis'antibodies. 
4. A significant sample of the residents of Utah 
should be skin tested to determine the incidence of H. 
capsulatum or ~. dermatitidis skin hypersensitivity. In 
conjunction with this approach, an effort should be made 
to isolate H. capsulatum and other fungi from chicken coops 
and ·pigeon nests. 
5. Better methods of inducing fungal infections in 
guinea pigs or rabbits may result from lowering the initial 
resistance of these animals with whole body ionizing radia-
tion or pretreatment with cortisol. Such depression of 
initial resistance to the fungi might produce a more 
uniform skin sensitivity among groups of guinea pigs or 
rabbits and so render these animals more suitable for skin 
test assay purposes. 
6. Polysaccharide skin test antigens should be pre-
pared from Sporotrichum schenkii and ~. immitis. These 
substances should be examined chemicallY,;3erologically and 
for their value as skin test agents. 
7. Further investigations of the immunization of 
mice with polysaccharides should be made. The basis of 
3 
'such 1nvestigati.on is the' hypo the'si s, that it is ,possible 
t'o' enhance, resistance against acute or chronic diseases 
by such immunization. 
8. Toxoplasma gondii seems to require living cells 
for its growth. These organisms are routinely maintained 
by serial intraperitoneal passage through mice. However, 
these organisms have been grown in tissue culture. A 
definitive study of the constituents of tissue culture 
necessary for the growth of 1. gondii might reveal a method 
for the artificial cultivation of this organism. 
9. The Sabin-Feldman dye test is not an entirely 
satisfactory serologic test for the detection of 1. gondii 
antibodies because live parasites must be used and the test 
involves microscopic examination. The use of a nonviable 
antigen in a serologic hemagglutina'tion test has been re-
ported. Confirmation of this report and further refinement 
of the method should be attempted. 
10. The mechanisms of immunity in toxoplasmosis have 
not been investigated. A study of the mechanisms of destruc-
tion of these parasites and the extent of the resistance 
produced in experimental animals by infection or by immuniz-
ation should be attempted. 
